11.10.1. Background {#s0005}
===================

In the decade since this chapter was first published ([@b1030]), there has been considerable progress in the understanding of the regulation of immunity. Advances such as the emergence of the innate immune system as a major theme in immunity following the discovery of the toll-like receptor (TLR) family ([@b1995]), the formalization of multiple macrophage phenotypes corresponding to the type 1 and 2 helper T (Th) cell subsets ([@b1680]), the rehabilitation of suppressor and regulatory T cells ([@b2155]), and the identification of new lymphocyte subsets, including Th3, Th17, and natural killer T (NKT) cells ([@b0895], [@b1635], [@b2335]), also have had considerable influence on the concept concerning the immunology of the male reproductive tract. Nonetheless, while there have been advances in our understanding of the interface between the male reproductive tract and the immune system, there is still much we simply do not know. The need to understand this interface and the potential implications for reproductive toxicology continues to be just as important as ever.

There is no doubt that the testis and the male germ cells in particular are susceptible to immunological damage. Clinically significant testicular autoimmunity, most commonly indicated by the presence of antisperm antibodies in the serum or ejaculate, is implicated in the case of 5--12% of all male infertility patients within the developed world ([@b0130], [@b2105]), but the incidence is much higher in populations where access to reproductive health care is limited ([@b0705]). Common factors suspected to contribute to testicular autoimmunity include reproductive tract infections, physical trauma, immune system dysfunction, and genetics. The release of spermatogenic antigens from the reproductive tract following vasectomy generally results in autoimmune responses, ranging in severity from sperm antibodies to orchitis, in both humans and experimental animals ([@b0045], [@b0765], [@b1390], [@b2785]). The potential for spontaneous testicular autoimmune disease in otherwise normal men remains poorly characterized, although studies in animals clearly indicate the possibility of such reactions in humans ([@b0805], [@b2790]). Complicating matters is the fact that the testis is an immunologically privileged tissue, in the sense that foreign tissue grafts into the testes of experimental animals survive for prolonged periods ([@b0155], [@b1015], [@b2970]). This dichotomy between immune susceptibility and privilege is indicative of a highly specialized interaction between the male reproductive system and the immune system, with potentially important implications for both systems. The objective of this chapter is to provide an overview of the current state of knowledge and to highlight issues for further consideration that may be of relevance to male reproductive toxicology.

11.10.2. The Interface between the Immune System and the Reproductive Tract {#s0010}
===========================================================================

The immune system is the body's protective arsenal against disease. It operates via the detection of potential aggressors, recognized through conserved motifs found on pathogenic organisms (innate immunity) or confrontation by completely novel (i.e., foreign) molecular structures (adaptive immunity) ([@b2860], [@b3145]). Immunity involves specialized cells possessing highly developed recognition and activation abilities (macrophages and dendritic cells) and the cells that carry out the protective responses: T and B cells in the case of adaptive immunity and NK cells and mononuclear or polymorphonuclear phagocytes (PMNs) in the case of innate immunity. Many of these cells play roles in both the recognition and effector arms of the immune response and in both innate and adaptive immunities ([Figure 1](#f0005){ref-type="fig"}). Innate immunity provides the rapid response elements of the immune system, but is limited in its attack repertoire. Adaptive immunity is much more flexible in its responses, but requires some time to become effective. Once the adaptive arm has been activated toward a particular pathogen, however, it can respond rapidly in the future due to the persistence of memory lymphocytes, which form the basis of immunization ([@b1735], [@b2430]). Figure 1Polarization in the immune system. The immune system is conceptually divided into innate and adaptive arms, with adaptive immunity further subdivided into type 1 (cell-mediated) and type 2 (antibody-mediated) responses. Triggering of the immune response involves the induction of inflammation by various agents, which may include infections, particulates, debris from damaged cells, or noxious agents. Innate immunity involves fixed pattern-recognition receptors, such as the Toll-like receptors, whereas adaptive immunity depends upon highly polymorphic receptors expressed by T cells (T cell receptors) and B cells (membrane-bound and secreted immunoglobulin). In general, type 1 responses are associated with cellular immunity, autoimmune reactions, and graft rejection. Type 2 responses involve antibody production by the B cells, but also play a more complex role in allergy, immunoregulation, and control of tolerance, favoring immune privilege. Within these divisions, various cell types, cytokines, chemokines, bioactive lipids, and other molecules interact to integrate or mediate the responses. The direction of the adaptive immune response type is determined primarily by the activity of the antigen-presenting cells (primarily dendritic cells) under the influence of cells with immunoregulatory capacity, such as macrophages, NK cells, and NKT cells, and either type 1 or type 2 cytokines produced locally. Several cell types and molecules play multiple roles within different functional divisions. Abbreviations: Mo, monocyte; NK, natural killer cell; PMN, polymorphonuclear cell; Th; helper T cell; B, B cell; T~reg~, regulatory T cell; M, macrophage; NKT, natural killer T cell; CTL, cytotoxic T cell; APC, antigen-presenting cell, ROS, reactive oxygen species; IFN, interferon; PGE, prostaglandin E; COX, cyclooxygenase; iNOS, inducible nitric oxide synthase; TNFα, tumor necrosis factor α; IL, interleukin; IL1ra, interleukin 1 receptor antagonist; TGFβ, transforming growth factor β; GC, glucocorticoid; MIF, macrophage migration inhibitory factor.

11.10.2.1. The Innate Immune Response {#s0015}
-------------------------------------

The innate immune system operates upon recognition by specific pattern-recognition receptors of specific motifs found on bacterial, viral, fungal, and protozoan pathogens. Functionally, these receptors have evolved to recognize pathogen-associated molecular patterns (PAMPs), such as bacterial lipopolysaccharides (LPSs), lipoproteins, peptidoglycans, and viral nucleic acids ([@b0250], [@b2300]). Unlike classical ligand receptors, these receptors respond to multiple ligands possessing related, but not necessarily identical, structures. The largest and best-studied class of pattern-recognition receptors is the TLRs, which are members of a larger family of proteins that include the interleukin (IL) 1 receptor (IL1R), and which share a conserved cytoplasmic domain called the Toll/IL1R (TIR) domain ([@b0035], [@b1990]). In humans, 10 functional TLRs (TLR1--10) have been identified ([Figure 2](#f0010){ref-type="fig"}). Mammalian TLRs 11--13 are known from laboratory rodent species, but are either pseudogenes or absent in humans ([@b2300]). Although they are particularly associated with cells of the monocyte lineage (i.e., macrophages and dendritic cells), these receptors are also found on certain T and B cells, as well as many fibroblastic and epithelial cells, including those of the male urogenital tract ([@b1455], [@b3130]). Significantly, ligands for some of the TLRs include endogenous molecules of mammalian origin ([@b0160], [@b1325], [@b2775], [@b3075], [@b3105]). TLR signaling occurs through engagement of crucial adaptor proteins, specifically myeloid differentiation primary response protein 88 (MyD88) or TIR domain-containing adaptor protein inducing interferon β (TRIF), via TIR domain interactions, leading to activation of tumor necrosis factor (TNF) receptor-associated factor 3 and 6 (TRAF3, TRAF6) ([@b0035], [@b1990], [@b1995]). Based on the TLR engaged, this results in nuclear translocation of the inflammatory transcription factor, nuclear factor kappa B (NFκB), activation of the Jun N-terminal kinase (Jnk) and p38 mitogen-activated protein (MAP) kinases, and induction of type 1 interferon (IFNα and IFNβ) production ([@b1105], [@b1675], [@b1905]). Figure 2The Toll-like receptors: major pathogenic ligands, adaptor proteins, signaling, and cytokine production. There are 10 active human Toll-like receptors (TLR1--10). TLR11--13 are present in rodents, and TLR11 is specific to the urogenital tract. The TLRs respond to a variety of pathogen-related molecules, usually forming homo- or heterodimers during signaling: for example, TLR2 can self-associate or combine with either TLR1 or TLR6 to mediate responses to various bacterial lipoprotein classes. TLR4 forms a complex with the receptor cofactor CD14, to facilitate binding of bacterial lipopolysaccharide (LPS). The TLRs can be subdivided into cell surface receptors, which largely respond to bacterial proteins, lipoproteins, and lipopolysaccharides, and intracytoplasmic receptors, which recognize single-stranded and double-stranded RNA (ssRNA and dsRNA) and CpG-containing DNA of viral or bacterial origin. Most TLRs signal via the adaptor protein MyD88 (myeloid differentiation primary response protein 88), except TLR3, which acts through the adaptor protein TRIF (TIR domain-containing adaptor protein inducing interferon β). Uniquely, TLR4 can interact with either MyD88 or TRIF, through engagement of the adaptor proteins Mal (MyD88 adaptor-like) or TRAM (TRIF-related adaptor molecule). Downstream signaling involves the tumor necrosis factor receptor-associated factors 3 and 6 (TRAF3 and TRAF6), activation of the transcription factors nuclear factor kappaB (NFκB) and interferon regulatory factor 1 (IRF1), or activation of the mitogen-activated protein kinases (MAP kinases) Jun N-terminal kinase (Jnk) and p38 to produce the *Fos*/*Jun* transcription factor activated protein 1 (AP1). These transcription factors interact to induce the expression of multiple proinflammatory genes, including interleukin (IL) 1α, tumor necrosis factor α (TNFα), inducible nitric oxide (iNOS), cyclooxygenase 2 (COX2), and interferon γ (IFNγ), or the type 1 interferons (IFNα, IFNβ) and TNFα. Note that many details of the signaling pathways have been omitted or truncated for the sake of simplicity.

The pattern-recognition receptor family also includes the nucleotide binding and oligomerization domain (Nod)-like receptor (NLR) family and the retinoic acid-inducible gene (RIG)-like helicases (RLHs) ([@b0200], [@b2740]). The NLRs detect various bacterial PAMPs within the cytosol. Some NLRs, such as Nod1 and Nod2, act via NFκB, while other NLRs work through induction of the cysteine protease caspase 1, which activates the proinflammatory cytokines IL1β and IL18 and initiates caspase-mediated proapoptotic pathways within the target cell. The RLHs, which detect the presence of viral RNA in the cytosol, activate both NFκB and production of type 1 IFNs.

Activation of innate immunity leads to inflammation, characterized by increased blood and lymphatic flow within the affected tissue and recruitment of immune cells to the site through production of chemokines and expression of vascular leukocyte adhesion molecules ([@b1865], [@b2160]). This mobilization of immune cells is accompanied by activation of complement, production of proinflammatory cytokines and acute-phase proteins, and stimulation of phagocytosis and killing of pathogens and infected cells by macrophages, PMNs, and NK cells, through production of proteases and other lytic proteins, and cytotoxic reactive oxygen species (ROS) and induction of apoptotic pathways ([@b2345]). Moreover, activation of innate immunity is responsible for initiation of the adaptive immune response, through production of regulatory cytokines and stimulation of the antigen-presenting cell (APC) abilities of dendritic cells, macrophages, and some B cells ([@b1335], [@b2595]).

Among the cell types that mediate the innate immune response, NK cells represent a special case. These cells are of the lymphocytic lineage, but they are capable of spontaneously attacking target cells without prior sensitization by exposure to antigen ([@b1860], [@b2955]). Through a complex of specific receptors on their surface, NK cells are able to recognize and directly target transformed cells, such as virally infected or tumor cells ([@b1445], [@b1860]). In this, NK cells provide a first-line of lymphocyte defense within the context of the innate immune response, but activated NK cells also participate in adaptive immunity, both as regulators and as effector cells of the response ([@b1835], [@b2245]).

11.10.2.2. The Adaptive Immune Response {#s0020}
---------------------------------------

Highly specific interactions between APCs and T cells, mediated via the polymorphic proteins of the major histocompatibility complex (MHC; the human leukocyte antigen (HLA) complex in humans) and antigen-specific T cell receptors (TCRs), are crucial to the adaptive immune response. The APCs process exogenous foreign proteins into short antigenic peptides, which are then incorporated into a structural groove on the external surface of the MHC protein complex during its assembly within the cell ([@b0480], [@b2395]). The TCR on the surface of a T cell that has specificity for the antigen binds to the antigen--MHC complex on the APC surface, which results in activation and proliferation of the T cell. Circulating T cells express one of two coreceptors, CD4 and CD8, as part of the TCR, which direct them to recognize antigens associated with either MHC class II or I proteins, respectively ([@b1235]). Antigens are presented to CD4^+^ T cells by the so-called professional APCs that express MHC class II antigens (i.e., dendritic cells, macrophages, and B cells) ([@b1025], [@b2820]). The CD8^+^ T cells recognize antigens presented in the context of MHC class I proteins, which are expressed by almost all cell types in the body. Activation of the T cell also requires physical interaction between the APC and T cell involving costimulatory ligand--receptor pairs, particularly CD28:B7 and CD40:CD40L, as well as the production of either type 1 cytokines (IFNγ, IL2, and IL12) or type 2 cytokines (IL4, IL5, IL10, and IL13) ([@b0450], [@b1025], [@b1870]). As a consequence, the activated T cell can have a number of different fates depending on the costimulatory molecules engaged and cytokines produced: activated CD4^+^ T cells may become type 1 helper (Th1) cells, which direct development of the cellular immune response involving cytotoxic CD8^+^ T cells, or they may become type 2 helper (Th2) cells, which promote the development of B cells into antibody-secreting plasma cells following interaction with their antigen ([@b0590]). Recently, a new Th effector cell subset (Th17) developmentally related to Th1 cells, but producing IL17, IL21, and IL22 has been described ([@b2075], [@b2335]). These Th17 cells direct a number of responses involved in protection against extracellular pathogens, including recruitment and activation of the major circulating PMN subset, the neutrophils, differentiation of B cells, and inflammatory reactions of epithelial cells. However, this cell subset has also been implicated in the development of autoimmune diseases and, along with Th2 cells, in allergy ([@b2000], [@b2075]). The absence of appropriate costimulatory molecule interactions and/or the presence of specific regulatory cytokines may also lead to T cell inactivation and deletion or generation of regulatory (i.e., suppressor) T cell subsets ([@b0885], [@b1960], [@b2155], [@b2735]). Finally, at least some activated T and B cell clones persist as memory cells following the resolution of the immune response ([@b0670], [@b2430]).

The initial antigen presentation and lymphocyte activation events generally occur in the secondary immune tissues, the local lymph nodes and spleen. Consequently, an effective lymphatic drainage is usually necessary for immune responses to develop in a particular tissue. However, since leukocytes recirculate through tissues, many of the important events, including antigen exposure and processing, antigen recognition by antigen-exposed lymphocytes, and lymphocyte maturation and proliferation, also occur at the reaction site itself ([@b0085], [@b0940], [@b2110]). Moreover, while it is generally accepted that the adaptive immune system is activated by the presence of foreign antigens, there is an alternative activation model that combines elements of both the innate and adaptive immune systems. This is encapsulated by the 'danger hypothesis,' which proposes that APCs respond to substances that cause or signal damage, rather than to those that are simply foreign ([@b1705]). These danger signals include CD40L, the early proinflammatory cytokines IL1β and TNFα, IFNs, and heat-shock proteins as well as substances that are normally found only inside cells (e.g., nucleotides, unmethylated CpG sequences in mammalian double-stranded DNA) and hyaluron breakdown products ([@b0815]). In this model, activation of the immune system occurs as a response to evidence of an extant threat, rather than toward a specific feature of the threat itself. This mechanism may contribute to the onset of certain autoimmune diseases.

11.10.3. Immunological Tolerance {#s0025}
================================

While an effective immune response is essential for protection of the host from a range of threats, the immune system also has its dark side. The capacity of the immune system for destructiveness is expressed in chronic inflammatory and autoimmune diseases, including those that affect the male reproductive tract ([@b2340], [@b2450], [@b2455], [@b2670]). These examples of an immune system seemingly out of control highlight the crucial importance of effective immunoregulation. At the center of immunoregulation is the concept of tolerance, or the capacity of the immune system to ignore certain molecular patterns, and the systems that restrain the immune response once its usefulness has expired.

Tolerance is the ability of the immune system to discriminate self from nonself. It is fundamentally based on the removal, inactivation, or suppression of self-reactive lymphocyte subsets, so that the immune system becomes effectively incapable of recognizing and reacting to these antigens. Induction of tolerance comprises both central and peripheral mechanisms. The central mechanism involves clonal deletion of T and B cell subsets that are potentially autoreactive, a process that normally occurs during gestation as part of the early maturation of the immune system ([@b1320], [@b1960]). Many details of this editing process remain incompletely understood, although the process involves broad expression by thymic medullary cells of self-antigens, including many endocrine tissue-specific antigens under the control of the transcription factor autoimmune regulator (Aire) ([@b1585]). Lymphocytes that recognize these self-antigens within the thymus during this process are targeted for destruction, effectively removing them from the lymphocyte repertoire. In addition, there are a number of complex mechanisms of peripheral tolerance, which involve the inactivation of antigen-specific lymphocytes in peripheral lymphoid organs by weak antigen stimulation in the absence of appropriate costimulation and the production of lymphocytes with immunoregulatory activities ([@b0885], [@b2155], [@b2735]). Peripheral immunoregulation involves several antigen-specific regulatory or suppressor T cell types, most notably the CD4^+^CD25^+^ regulatory T cell (T~reg~) subset. These cells selectively produce the immunosuppressive cytokines transforming growth factor β (TGFβ) and IL10, but also appear to act via direct contact with the cell being suppressed ([@b1890], [@b2150]). Other T cell subsets implicated in immunosuppression through their ability to produce TGFβ and IL10 include Th3 cells, Tr1 (T regulatory 1) cells, and γδ T cells, the latter being a minor T cell subset that is generally associated with epithelia ([@b1430], [@b1635], [@b2495]). The NKT cells, which are T cells with NK activity that possess unique restriction to glycolipid antigens presented by the MHC-like molecule CD1d, play a role in promoting graft survival and development of CD8^+^ regulatory/suppressor T cells through production of IL4 and IL10 ([@b0895], [@b1895], [@b2585]). The frontline NK cells are able to modulate adaptive immune responses by inducing dendritic cell death through contact-mediated lysis, but are also capable of producing IFNγ to stimulate the antigen-presenting activity of dendritic cells ([@b1450], [@b2245]).

It is the absence of tolerance that inhibits graft success in the very artificial condition of tissue transplantation. The immune cells of both the graft recipient and the donor tissue respond to one another, particularly with respect to polymorphic differences of the MHC proteins, leading to rejection of tissues that are not antigenically matched ([@b0905]). Even under normal conditions, failure of preexisting tolerance may occur through a number of mechanisms, leading to autoimmune disease. Somatic mutation of the antigen receptor expressed by a T or B cell may result in the creation of new self-reactive clones, subverting central tolerance ([@b0355]). Autoimmunity may also occur when the inflammatory response to an infection damages or overwhelms normal mechanisms of self-tolerance, or where the infection involves organisms that express antigens that may cross-react with self-antigens (molecular mimicry) ([@b1795], [@b2250]).

In addition to lymphocyte-mediated tolerance already discussed, the immune system possesses a repertoire of mechanisms that control and limit inflammatory and immune responses once they have commenced. Inflammation triggers the production by the adrenal gland of corticosteroids, which inhibit the production of proinflammatory cytokines and other immune mediators, reduce the expression of leukocyte adhesion molecules, and induce lymphocyte apoptosis ([@b0345], [@b1310]). During inflammation, immune cells themselves produce anti-inflammatory and immunosuppressive molecules, including prostaglandins D and J and the lipoxins ([@b1100], [@b1510]). Moreover, activated lymphocytes have a limited lifespan, undergoing a process of activation-induced cell death following upregulation of the extrinsic apoptotic signal mediated by interaction of the Fas receptor (CD95) with its ligand (Fas ligand: FasL or CD95L), eventually leaving behind a relatively small number of long-lived memory cells ([@b0670], [@b2430]). Likewise, there are mechanisms to inhibit antibody activity and promote antibody clearance ([@b1180]).

11.10.3.1. The Concept of Immune Privilege {#s0030}
------------------------------------------

Classically, the term immune privilege applies to organs or tissues where survival of foreign grafts may be prolonged ([@b0155]), but more accurately, the term denotes tissues where immune responses are inhibited or suppressed ([@b1040]). Privileged tissues include the brain, eye, pregnant uterus, and the testis. Initially, privilege was attributed to deficient lymphatic drainage in such tissues, or physical barriers that prevented immune cells from gaining access ([@b0155]). Several privileged tissues do possess highly specialized epithelial or endothelial cell barriers that may sequester antigens away from the normal immune surveillance: the best characterized of these are the blood--brain barrier and the trophoblast in the pregnant uterus ([@b1160], [@b2635]). However, physical exclusion is now considered an overly simplistic explanation for immune privilege, given that lymphocyte and antibody responses to introduced antigens occur even in sites where grafts can survive for extended periods ([@b1020], [@b1315], [@b2690]). Although barrier mechanisms and altered lymphatics may be contributory factors in some tissues, immune privilege is a consequence of tissue-specific specialized systems for controlling, subverting, or preventing local inflammatory or immune activation responses ([@b1040]).

11.10.3.2. Testicular Organization and Immunity {#s0035}
-----------------------------------------------

The male reproductive tract comprises the paired testes, associated epididymis and vas deferentia, accessory glands (chiefly the prostate and seminal vesicles), and the urethra. These tissues represent a diversity of structures and, consequently, the immunology of each tissue retains distinctive features ([@b1055]). Best studied in this context is the testis, which comprises two discrete tissue compartments, the seminiferous tubules and the interstitial tissue. The interstitial tissue contains the blood supply and lymphatics, as well as the innervation of the testis ([@b0740], [@b2505]). The epithelium of the seminiferous tubules is entirely avascular. Within the seminiferous epithelium, spermatogenesis is supported and maintained by the Sertoli cells, which remain in physical contact with the developing germ cells at all times. During spermatogenesis, a stem cell spermatogonium sitting on the basement membrane of the seminiferous tubule becomes committed to a series of mitotic divisions, producing a cohort of spermatocytes. The spermatocytes subsequently move toward the tubule lumen, passing through tight junctions between adjacent Sertoli cells, into the highly specialized environment of the adluminal compartment ([@b2890]). Within this compartment, the spermatocytes divide meiotically to produce haploid spermatids and then undergo differentiation into spermatozoa, which are ultimately released into the lumen of the tubule leaving behind the majority of their cytoplasm to be digested by the Sertoli cells as residual bodies. The released spermatozoa are swept by fluid secreted from the Sertoli cells toward the rete testis, a collecting structure lined by a simple epithelium that is connected to the adjacent epididymis by a series of efferent ducts. Sperm mature and are stored in the epididymis, until they are either released through the vas deferentia at the time of ejaculation or removed by epididymal phagocytes ([@b0165], [@b2350]).

The process of spermatogenesis is highly organized, with multiple generations of developing germ cells in each region of the epithelium maintaining distinct, progressing cellular associations or stages, which comprise the cycle of the seminiferous epithelium (14 stages in the rat, 12 stages in the mouse, 6 stages in man). These stages are arranged in sequence along the length of each seminiferous tubule, creating waves of coordinated spermatogenic development ([@b0430]). Spermatogenesis is maintained and controlled by follicle-stimulating hormone (FSH) and testosterone, the latter being produced by the Leydig cells in the interstitial tissue under the influence of luteinizing hormone (LH). Importantly, FSH and testosterone act upon Sertoli cells and not directly on the germ cells ([@b1740]). These hormones determine the efficiency of the spermatogenic process largely by controlling germ cell survival, that is, the balance between differentiation and apoptosis ([@b1700], [@b2360]). In order to maintain the cycle of the seminiferous epithelium, the developing germ cells and Sertoli cells are engaged in continuous intercellular communication, although the precise nature of this communication remains very poorly understood.

The testis, and spermatogenesis in particular, presents a unique challenge for the immune system. Although there are reports of direct drainage of some lymphatic vessels to the thoracic duct, there is no evidence of any structural or functional deficiency in the efferent lymphatics of the testis, and allogeneic cells injected into the rat testis induce typical immune responses in the draining lymph nodes ([@b0740], [@b1020], [@b1215], [@b1845]). Nonetheless, the vast majority of spermatogenic differentiation occurs long after central tolerance is established and, while thymic expression of some testicular antigens is under the control of the Aire transcription factor, it is obvious from clinical and experimental studies that germ cells express multiple autoreactive antigens and are highly immunogenic when brought into contact with the immune system ([@b1210], [@b2780]). Surprisingly, this is a problem for a relatively small cohort of men only, and autoimmune orchitis or epididymitis is rarely reported in humans, except in the context of local infection ([@b1415]). Even allowing for the possibility that most cases of spontaneous autoimmune reactions against the developing germ cells are never diagnosed, since they would occur early in reproductive life, and would simply present as spermatogenic failure during infertility work-ups ([@b2450], [@b2455]), why are such reactions not more common?

11.10.3.3. The Role of the Blood--Testis Barrier and Immune Ignorance {#s0040}
---------------------------------------------------------------------

It is widely believed that the blood--testis barrier plays a role in protecting testicular antigens from the immune system. However, as a result of a common misunderstanding of the nature of this vitally important structure, its actual role is usually overestimated. Critically, the blood--testis barrier involves highly specialized occluding or tight junctions between adjacent Sertoli cells, which separate the spermatogonial and early meiotic cells from the majority of meiotic and postmeiotic germ cells ([@b0675], [@b2520]). The structure and functions of the barrier do not need to be discussed in detail here, as this topic is covered in much more detail in other chapters in this volume (see Chapter 11.05). By preventing the passage of most molecules between adjacent Sertoli cells, the blood--testis barrier allows the creation of a highly specialized biochemical environment essential for meiotic development ([@b0415], [@b0925]). It also blocks access by lymphocytes, complement, and antibody ([@b0210], [@b3110]). By contrast, the vascular endothelium and peritubular cells surrounding the tubules play a negligible role in maintaining the blood--testis barrier in practical terms, and immune cells and proteins have relatively free access to the interstitium and basal seminiferous epithelium ([@b1660], [@b3110]). Thus, this barrier is quite different in properties and function from the blood--brain barrier, located on the vascular endothelium, or the trophoblastic barrier of pregnancy, which entirely segregates the developing fetal tissues from the maternal host.

A reinterpretation of the blood--testis barrier as a series of cellular elements that protects the germ cells from harmful influences has been proposed more recently ([@b0180]). In this model, the blood--testis barrier consists not only of the structural elements already discussed, but also the efflux pump barrier system involving the drug transport proteins *p*-glycoprotein and the multidrug resistance-associated protein-1 expressed on the capillary endothelium, peritubular myoid cells, and the basal aspect of the Sertoli cells ([@b0185], [@b1780]). While these elements may certainly be important for protection of the testis against toxic agents, their contribution to immunoregulation is probably marginal.

Several lines of evidence indicate that the blood--testis barrier cannot account for all manifestations of immune privilege in the testis. The barrier does not prevent exposure of germ cell antigens to the immune system, as antibodies and lymphocytes specific for spermatogenic antigens appear to be a normal feature of the circulating immune repertoire even under normal conditions ([@b2800]). Spermatogenic cell autoantigens are not confined behind the Sertoli cell tight junctions, and are expressed by spermatogonia and the early spermatocytes ([@b1655], [@b1660], [@b3110]). Moreover, the barrier does not extend into the rete testis or beyond. Significantly, orchitis can be passively transferred to naive mice using lymphocytes obtained from mice with active autoimmune orchitis, with the initial reaction concentrated in the interstitial tissue around the rete testis ([@b1655], [@b2795]). A similar initial pattern of development of orchitis within the rete testis region has been observed in mice actively immunized with viable germ cells ([@b1200]). In many seasonally breeding species, annual regression of the blood--testis barrier occurs without inducing overt inflammation or autoimmunity ([@b2115], [@b2790]). Finally, the blood--testis barrier cannot explain the enhanced survival of grafts within the interstitial tissue (i.e., outside the barrier) and does not explain survival of autoantigenic sperm in the epididymis, or remainder of the male reproductive tract. However, while the blood--testis barrier does not explain immune privilege in the testis, the breach of the tight junctions comprising the barrier remains a critical event in the development of any autoimmune destruction of the seminiferous epithelium during orchitis ([@b1650], [@b1655]).

Recognition of antigen in association with MHC is essential to normal adaptive immune responses, and reduced expression of MHC class I (HLA-A, HLA-B, and HLA-C in humans) and class II proteins (HLA-D) appears to be an important feature of immune-privileged tissues and tumors ([@b0820], [@b0950], [@b1010], [@b2935]). Reduction in class I and II expression reduces the likelihood of immune-activating events involving CD4^+^ helper T cells and cytotoxic CD8^+^ T cells in the tissues. Studies indicate a characteristic absence of expression of MHC proteins on the cells of the seminiferous epithelium under normal conditions ([@b0950], [@b1010], [@b1610], [@b2795]), although both MHC classes are expressed in human spermatozoa ([@b1685]). There is evidence from studies on mouse Sertoli cells in culture that MHC class II expression can be upregulated in these cells by IFNγ ([@b0525]). In contrast to the seminiferous epithelium, both MHC class I and II proteins are expressed throughout the testicular interstitial tissue: MHC class I is expressed on most interstitial cells, including the Leydig cells ([@b0950], [@b2170]), while testicular macrophages and dendritic cells express MHC class II ([@b0950], [@b1010], [@b1050], [@b1655], [@b2795]). Thus, it appears unlikely that a lack of APCs is a contributing factor in testicular immune privilege, although differences in the number and distribution of MHC class II-expressing cells in the interstitial tissue of different species or strains may help to explain differences in susceptibility to autoimmune orchitis ([@b0770], [@b1390], [@b2725]).

The fact that the testis is not isolated from the immune system, yet can tolerate both endogenous (auto-) antigens associated with spermatogenesis and exogenous (allo- or xeno-) antigens expressed by grafts, is evidence of tissue-specific inhibition of the immune response. The question then arises: if immune responses against exogenous and endogenous antigens are inhibited in the testis environment, does the testis display a reduced capacity to deal with infections and greater susceptibility to certain kinds of tumors? There is evidence that immunity may be compromised in some situations, for example, the tendency toward relapsing acute lymphocytic leukemia in the testes ([@b1145]), and several systemic viral and mycobacterial infections target the testis, including mumps, human immunodeficiency virus, tuberculosis, and the severe acute respiratory syndrome virus ([@b1415], [@b1950], [@b3050]). However, the testis does not appear to be immunodeficient. Even in comparison with the rest of the male reproductive tract, orchitis due to ascending infections is relatively rare ([@b1415], [@b1935]). Moreover, the extremely variable level of success of experiments by different groups using different transplant models has shown that immune privilege of the testis is both limited and conditional ([@b0645], [@b1015], [@b1640], [@b2480], [@b2500]). Just what are these necessary conditions, however, remains poorly defined. Studies indicate that the effector arm of the immune response is intact within the testis, and it is the ability to recognize and react toward foreign antigens and/or mount a normal inflammatory response that is suppressed ([@b1010], [@b1015], [@b1650], [@b1655]).

In summary, there appears to be a potentially unique functional interaction between the testis and the immune system, which involves control of the mechanisms normally involved in immune activation, in order to limit adaptive immune responses without drastically compromising the ability of the testis to protect itself when required.

11.10.3.4. Testicular Leukocytes {#s0045}
--------------------------------

Although their presence and influence is almost universally neglected, macrophages, lymphocytes, and PMNs have varying degrees of access to the interstitial tissue of the testis ([Table 1](#t0005){ref-type="table"}). They are generally excluded from the seminiferous epithelium under normal conditions. Over the past 10 years, studies have started to fill in some of the details concerning these cells. Table 1Leukocytes of the normal mammalian testisCell typeCharacteristicsLocal functionsMonocytes/macrophagesNumerous, multiple subsetsPhagocytosis, tissue remodeling, Leydig cell development, innate immunity (antimicrobial), immunoregulationDendritic cellsPresentAntigen presentation, immunoregulationT cellsCD4^+^, CD8^+^, and NK T subsetsAdaptive immunity, immunosurveillance, immunoregulationNK cellsPresentInnate immunity, immunosurveillance, immunoregulationMast cellsSpecies-specific distributionVascular control, innate immunityEosinophilsSpecies-specific distributionVascular control, innate immunityNeutrophilsNot normally presentInflammation, phagocytosis, innate immunity (antimicrobial)

### 11.10.3.4.1. Macrophages {#s0050}

Macrophages are by far the most prominent immune cells in the testis. They are found in the testes of all mammalian species so far examined, but are particularly numerous in human, rat, and mouse testes ([@b0790], [@b1155], [@b1790], [@b1820], [@b2850], [@b2895]). Typically, macrophages arise from myeloid precursors in the bone marrow and circulate in the blood as monocytes. They are capable of adopting a broad range of structural and functional phenotypes that are largely dictated by the tissues in which they become resident ([@b1680], [@b2830]). Characteristically, they are robustly phagocytic and possess a potent arsenal of antimicrobial and cytotoxic activities, such as the ability to generate large amounts of ROS. They produce many immunoregulatory products, including cytokines, eicosanoids (prostaglandins, thromboxanes, leukotrienes, and lipoxins), and nitric oxide, all of which are important in establishing and controlling the inflammatory process, but also have important roles in tissue remodeling, healing, and normal homeostasis. All macrophage lineages can express MHC class II antigens and have the capacity to present to CD4^+^ helper or T~reg~ cells ([@b2820]). Thus, macrophages are the cells that link innate and adaptive immunity, and dendritic cells are a highly specialized macrophage subset that is particularly effective in this role ([@b1025]).

Testicular macrophages have been most extensively studied in the rat, with a few studies also in the mouse and human. Studies in the rat indicate that they are heterogenous in their morphology and functions ([@b0335], [@b0870], [@b1205], [@b2895]). Their absolute numbers are primarily under Leydig cell control, but evidence suggests that FSH acting via the Sertoli cell has a role in regulating their functional activity ([@b0655], [@b0660], [@b0845], [@b2895]). Macrophages accumulate within the interstitial tissue at the time of puberty, and play critical roles in the normal development of the testis, particularly by promoting the proliferation and maturation of the Leydig cell population ([@b0440], [@b0835], [@b0840], [@b0990], [@b1220], [@b2210], [@b2850]). Through their ability to produce a broad array of growth factors, prostanoids, and vasoactive regulators, other developmental and homeostatic roles within the testis may be predicted as well.

Data concerning the immunological functions of testicular macrophages are based on a relatively small number of studies in either the rat or the mouse, and are patchy at best. Indeed, there is some evidence for distinct differences even between these two closely related species. In general, testicular macrophages have intact phagocytic, cytotoxic, and antimicrobial functions ([@b1820], [@b2930]). Rat testis macrophages express MHC class II antigens ([@b1010], [@b1050], [@b2895]), but display a reduced capacity for lymphocyte activation *in vitro* ([@b1340]). Testicular macrophages in the human and mouse also express MHC class II, although expression in the mouse appears to be more restricted ([@b0950], [@b1205], [@b2175], [@b2795]). A lack of expression of the essential costimulatory molecules, B7-1 (CD80) and B7-2 (CD86), has been reported in the mouse testis as well ([@b2375]). Studies also indicate that macrophages from the rat testis have a significantly reduced ability to produce proinflammatory cytokines, such as IL1β and TNFα, following activation ([@b0870], [@b1005], [@b1340], [@b1345], [@b1760]), and stimulated mouse testicular macrophages produce the anti-inflammatory/immunosuppressive cytokines IL10 and TGFβ~1~ *in vitro* ([@b0335], [@b0340]). While the data suggest that testicular macrophages may have a predominantly anti-inflammatory and/or immunosuppressive phenotype, this has yet to be formally established. Furthermore, dendritic cells, which are a highly specialized macrophage subset also found within the testicular interstitium ([@b0750], [@b1130], [@b1205], [@b2290]), presumably play a more important role in controlling immune responses to antigens within the testis ([@b0750], [@b2290], [@b2285]).

In the rat testis, macrophages can be discriminated by their differential expression of two molecular markers recognized by the antibodies ED1 and ED2. Antibody ED1 recognizes the lysosomal protein CD68, which is associated with antigen processing and presentation ([@b0930]), while ED2 recognizes the scavenger receptor CD163 ([@b0730]). CD163 is involved in the clearance of hemoglobin:haptoglobin complexes and the resolution of inflammation ([@b2140]). About 80--85% of rat testicular macrophages express this scavenger receptor and about half of these cells also lack expression of CD68 ([@b0870], [@b1765], [@b2895]). In the human testis, most macrophages appear to be CD68^+^, but expression of CD163 is a feature of a subset of these cells as well ([@b0790]). The heterogeneous expression of these two markers points to the existence of multiple populations of testicular macrophages, and evidence suggests that these phenotypic differences also correspond to functional differences. In the normal and inflamed adult rat testis, CD163^+^ cells lack expression of the key inflammatory mediators IL1β and inducible nitric oxide synthase (iNOS), as measured by double-label immunohistochemistry, but these molecules are detectable in CD68^+^ cells that do not express CD163 ([@b0870], [@b1970]). Indeed, purification of CD163^+^ macrophages from the rat testis using immunomagnetic beads confirms that these cells have reduced capacity to produce IL1β, IL6, or NO upon stimulation, although they retain the ability to produce prostaglandins ([@b0870]; Hedger, unpublished data). This suggests that the CD163^+^ macrophages have reduced proinflammatory activities, while the CD163-negative testicular macrophage population retains normal proinflammatory functions. This observation is important because macrophages that express CD163 and produce IL10, but display reduced expression of CD80, CD86, iNOS, TNFα, and IL1β, are polarized toward the immunoregulatory M2 subset ([@b1680], [@b2540]). The M2 macrophage subset is analogous to the Th2 subset among T cells, and is associated with late-stage inflammation and its resolution, as well as tumors and other immunologically privileged tissue sites. It would appear that a significant proportion of the resident macrophages of the testis possess an immunoregulatory phenotype that is consistent with immune privilege. The functional roles of this macrophage population, as well as those of the macrophages that appear to retain normal inflammatory (i.e., M1 subset) properties, demand particular attention if we are to understand the unique immunological environment of the testis.

### 11.10.3.4.2. Lymphocytes {#s0055}

While the functions and regulation of lymphocytes within the testis have yet to be properly characterized, by their presence alone these cells will have significant effects on testicular events. It may also be assumed that, in contrast to the largely resident population of testicular macrophages, lymphocytes circulate through the testis. This may be because they possess specificity for testicular antigens, or because they have been activated during earlier intratesticular inflammatory or infectious events ([@b0510], [@b2600]). Quantitative studies in the rat indicate that, at any given time, lymphocytes are approximately 10% as numerous as the macrophages in the normal testis ([@b1065], [@b1080], [@b2895]). In the rat and mouse, intratesticular lymphocytes express T cell and NK cell markers, and comprise distinct T cell, NK cell, and NKT cell subsets ([@b2770]; Hedger, unpublished data). Both T cell and NK cell markers are expressed by lymphocytes in the human testis as well (Hedger, unpublished data). B cells are not usually observed in normal tissues, and this includes the testis. In the rat, many T cells possess a memory phenotype, as would be expected ([@b1080], [@b2770]). Reanalysis of the data for individual animals across several studies suggests that their numbers tend to be proportional to the numbers of macrophages, but gradually increase with the age of the animal ([@b1080], [@b1065], [@b2895]). Among the T cells of the testis, there is a strong bias toward the CD8^+^ (i.e., MHC class I restricted, largely cytotoxic) subset ([@b1080], [@b2175], [@b2275], [@b2770], [@b2895]). The prominence of NK cell subsets in the testis is also intriguing given the reduced MHC class I antigen expression in the seminiferous compartment, which would tend to make these cells more susceptible to NK cells ([@b1445]). Consistent with the anti-inflammatory/immunosuppressive phenotype of the major testicular macrophage subset, T cells and NKT cells in the rat testis constitutively produce IL10 (Hedger, unpublished data). While much remains to be discovered, the existing data concerning the types and activity of testicular lymphocytes are consistent with maintaining immune privilege (i.e., the presence of immunoregulatory lymphocytes) and increased innate immunity (i.e., cytotoxic cell activity).

### 11.10.3.4.3. Polymorphonuclear Cells {#s0060}

Evidence that PMNs are important in testicular function comes from the fact that mast cells and eosinophils are significant elements of the interstitial tissue in many species. In the rat, mouse, dog, cat, bull, and deer, both cell types are largely absent from the testicular parenchyma, but are associated with blood vessels in the testicular capsule ([@b0070]). Mast cells are found throughout the interstitial tissue in equine and human testes ([@b0070], [@b1945], [@b3060]), and both mast cells and eosinophils are present in porcine species ([@b0070]). The role of these cells in vascular control and innate immunity can be predicted, but they may also play immunoregulatory roles, as mast cells do in other tissues ([@b0810]).

In humans, testicular mast cell numbers are increased in infertility ([@b1755], [@b1885], [@b3060]), but decline with advancing age ([@b1945]). The possibility that they accumulate due to past immune events needs to be considered, but they also appear to be actively regulated. In the adult rat testis, mast cell proliferation is under the control of the Leydig cells, suggesting that these cells produce an inhibitor of mast cell activity ([@b0830], [@b2895]). Neonatal estrogen treatment increases mast cell numbers in the rat testis ([@b0850], [@b0830]), and a relationship with elevated Leydig cell aromatase activity is suggested by the prevalence of these cells in boar and equine testes ([@b0700], [@b2220]). Neutrophils are found in the testis only under conditions of testicular inflammation or damage ([@b0870], [@b1380], [@b1985]).

11.10.3.5. Immunity in the Epididymis, Accessory Glands, and Urogenital Tract {#s0065}
-----------------------------------------------------------------------------

The majority of this chapter deals with the testis because it is the primary source of male gametes and hormones, and damage to this organ tends to have more significant consequences for fertility. The remainder of the male reproductive tract comprises the epididymis, vas deferens, accessory glands, and the urethra, which are all epithelial-lined ductal tissues of varying complexity. The immunology of these tissues appears to be quite distinct from that of the testis. While it is true that sperm spend relatively little time within most of these tissues, mature sperm reside within the epididymis for extended periods without provoking an overt immune response, and inflammation and immune cell activity can nonetheless have damaging effects in this organ.

Significantly, these tissues possess normal interepithelial cell junctions, but lack a completely occluding intercellular structure analogous to the blood--testis barrier ([@b1515], [@b2120]). Secreted IgA, which lacks the ability to bind complement and possesses principally anti-inflammatory properties as a result, plays an important role in the male urogenital tract ([@b0435], [@b2165], [@b2195]), and the immunology of these organs tends to more closely resemble that of other elements of the mucosal immune system, such as the gastrointestinal and respiratory tracts ([@b0195], [@b0435], [@b1800]). In the absence of the specialized mucosal-associated lymphoepithelial tissue normally found in the gastrointestinal and respiratory tracts, it is likely that the epithelial cells themselves, together with the numerous intraepithelial and stromal macrophages and lymphocytes that are normally found within these tissues, mediate local immunoregulatory mechanisms ([@b0165], [@b0680], [@b0715], [@b2275], [@b2195], [@b2730], [@b3090]). A better understanding of the immunology of these tissues is important. Inflammation, infection, and physical damage can lead to immune reactions against the sperm, which in turn may compromise fertility. Moreover, many men suffer from chronic pelvic pain, generally manifesting as epididymitis or prostatitis in the absence of a detectable infection, a condition that almost certainly involves chronic inflammatory processes within the male reproductive tract.

11.10.4. Immunoregulation in the Male Reproductive Tract {#s0070}
========================================================

As outlined in the preceding sections, the testis is able to support immune privilege without sacrificing immune surveillance and protection. The mechanisms responsible for this immunological balancing act are still far from understood, but a number of inflammatory and immunoregulatory systems that operate within the testis have been investigated in varying degrees of detail. It is perhaps not very surprising that many of these regulatory systems also impact upon normal testis physiology, in addition to their immunological and pathological roles.

11.10.4.1. The Immunoregulatory Roles of Testicular Somatic Cells and Germ Cells {#s0075}
--------------------------------------------------------------------------------

Given that the types and properties of leukocytes found within the testis environment are consistent with immunoregulation and enhanced innate immunity, the focus should be on which testicular elements are involved in creating this potentially unique immunological environment. Most attention in this regard has been directed toward the highly versatile Sertoli cell.

Evidence that the Sertoli cell possesses specialized immunoregulatory properties comes from cotransplantation studies. Sertoli cells from immature rat, murine, or porcine testes display extended survival as allografts or xenografts, and cotransplantation of Sertoli cells or testis cell mixtures containing these cells confers increased survival on neural cell xenografts, and pancreatic islet allografts and xenografts ([@b2390], [@b2475], [@b2645]). The ability to form a physical barrier through inter-Sertoli tight junctions and the fact that Sertoli cells have reduced MHC expression ([@b0950], [@b1385], [@b2390], [@b2805]) undoubtedly enhance their potential to avoid T cell activation both in the intact testis and in engraftment studies. Moreover, a soluble form of the nonclassical MHC class Ib molecule HLA-G is produced by the Sertoli cells, as well as spermatocytes, spermatids, and some interstitial cells, in the rhesus monkey testis ([@b2365]). This molecule has been implicated in apoptosis of alloreactive CD8^+^ cytotoxic T cells ([@b0785]). Sertoli cells display lymphocytotoxic activities and produce molecules with immunosuppressive activity, such as TGFβ1 ([@b0540], [@b2645], [@b3015], [@b3095]) and FasL ([@b0205], [@b3095]). An active immunoregulatory role has also been suggested: murine Sertoli cells treated with IFNγ increase expression of MHC class II molecules and the negative costimulatory ligand B7-H1, and stimulate T~reg~ numbers in culture ([@b0525]). The ability of the Sertoli cell to suppress other critical inflammatory events through expression of complement regulatory proteins ([@b1480]) and secretion of inhibitors of lymphocyte cytotoxic activities ([@b2545]) is also likely to be important. Finally, Sertoli cells possess an enormous capacity for phagocytosis of senescent cells, cell debris, and other potentially antigenic complexes, which could otherwise activate an immune response.

Data concerning immunoregulatory roles of other testicular cells are less comprehensive. The evidence clearly indicates a role for Leydig cells in recruiting macrophages into the testis, although testicular macrophage function may actually be determined by the Sertoli cells ([@b0655], [@b0660], [@b0845], [@b2895]). Leydig cells also produce various steroids, proteins, and other factors with immunosuppressive activity, and inhibit lymphocyte activity *in vitro* ([@b0290], [@b1075]). Peritubular cells, like Sertoli cells, produce immunoregulatory TGFβ family members ([@b1395], [@b1880], [@b2040]). The possibility that the germ cells themselves have a direct effect on immune cells has also been considered ([@b1165]), although it seems more likely that germ cells may influence immune responses indirectly by inducing immunoregulatory activities of the Sertoli cells and other somatic cells.

11.10.4.2. Immunoregulatory Systems in the Testis {#s0080}
-------------------------------------------------

### 11.10.4.2.1. Toll-like receptors {#s0085}

The relatively recent discovery of the TLRs has radically expanded our understanding of innate immunity and promises to do the same for testicular immunology. In addition to their predictable expression on testicular macrophages and dendritic cells, TLR mRNA, protein, and/or ligand responses have been described in several other testicular cells. Rat and mouse Sertoli cells express TLR2, 3, 4, and 5 ([@b0245], [@b2265], [@b2610], [@b3005]). TLR1, 10, and 11 mRNA expression has been observed in rat Sertoli cells ([@b0245]), and low levels of TLR6, 7, and 13 mRNA have been detected in mouse Sertoli cells ([@b2265], [@b3005]). In the rat, germ cells also produce mRNA for TLR2, 3, and 4 in a stage-specific manner, and the peritubular cells express TLR3 and 11, along with low levels of TLR2, 4, and 6 ([@b0245]). Rat Leydig cells express TLR2 mRNA and low levels of TLR10 ([@b0245]). However, the cytoplasmic receptors TLR8 and 9 have yet to be observed in any nonmyeloid testicular cell type. Of the other pattern-recognition receptors, Nod1 mRNA has been detected in rat Sertoli cells, peritubular cells, and spermatogonia, while Nod2 was detected in spermatogonia only ([@b0245]).

Expression of TLRs and other pattern-recognition receptors in the testis is obviously important for responses toward intratesticular pathogens. Infections and inflammation, both systemic and localized, have negative effects on testicular function, resulting in reduced androgen production, lowered sperm counts, and temporary loss of fertility ([@b0010], [@b0125], [@b0385]). Presumably, TLRs expressed by the Sertoli cells and germ cells are necessary to detect pathogens that ascend the reproductive tract and, as a consequence, lie behind the blood--testis barrier. This expression within the seminiferous epithelium also suggests a mechanism whereby inflammation can directly inhibit spermatogenesis. Activation of Sertoli cells by TLR ligands induces production of inflammatory mediators, such as IL1α, IL6, and NO, which have direct effects on germ cell development and Leydig cell steroidogenesis ([@b0865], [@b2620], [@b2625], [@b1975], [@b2265], [@b3005]). Moreover, while inhibition of Leydig cell steroidogenesis during inflammation may involve indirect effects at the level of the pituitary, or the actions of inflammatory mediators produced by the testicular macrophages and Sertoli cells, there is evidence that these cells can also respond directly to TLR ligands ([@b0245], [@b3030]).

Although the TLRs have evolved to recognize pathogen-derived molecules, such as LPS (TLR4) and bacterial lipoproteins (TLR2), recent data show that they can also be activated by certain endogenous molecules. The ability of preparations of some endogenous molecules, such as heat-shock proteins, to activate TLR signaling is now attributed to contamination of these preparations by bacterial products ([@b2775]), but there is convincing evidence that mammalian mRNA is a ligand for TLR3 ([@b1325]) and mammalian CpG DNA can activate TLR9 ([@b3075]). The high mobility group box chromosomal protein 1 (HMGB1), produced by both spermatogonia and Sertoli cells, is a TLR2 and 4 ligand ([@b3105], [@b3120]). Expression of TLRs by the Sertoli cells under normal conditions, therefore, suggests a potential role for these receptors in responding to these endogenous ligands.

### 11.10.4.2.2. The interleukin 1 family {#s0090}

IL1 is the best studied of all the cytokines normally expressed in the testis. It is produced in two forms, α and β, which are encoded by separate genes and share approximately 25% sequence homology. Both forms act through the same receptor complex (IL1R1), and exert a similar range of proinflammatory and physiological effects ([@b0635], [@b1995]). Most IL1 signaling occurs through activation of the MyD88/TRAF and Jnk/p38 MAP kinase pathways, thereby regulating many proinflammatory genes through stimulation of the transcription factors NFκB and activated protein 1 (AP1) ([@b1745]). The IL1s are synthesized as precursor proteins, which are cleaved to produce 17 kDa active proteins. In the case of IL1α, the precursor possesses low-level biological activity, but the IL1β precursor protein is inactive ([@b0265], [@b2925]). The precursor of IL1β is cleaved by the IL1 converting enzyme (ICE, caspase 1) during the process of secretion, whereas IL1α is cleaved by the calcium-dependent membrane-associated cysteine protease (calpain) or by extracellular proteases ([@b2745], [@b2925]). IL1β is produced by activated monocyte/macrophages and is the main secreted form during inflammation, whereas IL1α is more commonly found within the cell, where it may act as an autocrine or paracrine growth factor involved in direct cell-to-cell communication.

In addition to the prototypical IL1α and IL1β, the IL1 family comprises a number of structurally related proteins, which appear to have arisen by gene duplication ([@b0665]). The closest structurally to IL1α/β is IL18, which is processed by caspase 1 activity, but acts via a separate receptor rather than IL1R1 ([@b0910]). Another member of the family, which does bind to IL1R1 but lacks the ability to transduce a signal, blocks IL1α/β action and is called IL1 receptor antagonist (IL1ra) ([@b0080]).

Production of IL1α is constitutively high in the normal testis, as IL1α is produced by the Sertoli cells in a cyclical manner within the mature seminiferous epithelium ([@b1260], [@b2575]). Its production is driven by the developing germ cells and by phagocytosis of the residual cytoplasm cast off by the spermatids at the time of their release into the tubule lumen ([@b0865], [@b2685]). Sertoli cell IL1α production is also stimulated by LPS, but not by FSH ([@b2625]). Production of IL1β by the normal testis is low, but is upregulated in a subset of testicular macrophages and the Leydig cells during inflammation ([@b0860], [@b1260], [@b1970]). Curiously, the majority of this secreted testicular IL1β exists as the precursor ([@b1970]).

The receptor IL1R1 has been localized to germ cells and Sertoli cells ([@b0900]). IL1α stimulates DNA synthesis in spermatogonia (i.e., mitosis) and early spermatocytes (i.e., meiosis), proliferation of immature Sertoli cells, and a number of activities of the mature Sertoli cell that support spermatogenesis, such as the production of lactate and transferrin ([@b0960], [@b1120], [@b1925], [@b2095], [@b2180], [@b2575]). It also regulates the ability of the Sertoli cell to maintain contact with other Sertoli cells and the developing germ cells, by altering the Sertoli cell cytoskeleton ([@b2415]). In the interstitium, both IL1α and IL1β suppress LH-stimulated androgen production by adult Leydig cells through inhibition of steroidogenic enzyme activity ([@b0970], [@b3040], [@b3045]). IL1ra is produced by the Sertoli cell, and is stimulated by FSH, IL1, and LPS ([@b3125]). Presumably, its role is to regulate the activity of IL1α/β within the testis.

Both IL18 and its receptor have been found in the seminiferous epithelium, with IL18 mRNA and protein localized to spermatocytes and round spermatids ([@b2630]). As is the case for IL1β, the majority of IL18 produced within the testis is in the precursor form, indicating that the processing of these cytokines by caspase 1 in the testis is an area requiring more investigation. IL18 stimulates spermatogonial DNA synthesis in cultures of rat seminiferous tubules, without influencing germ cell apoptosis ([@b2630]). Another member of the family localized to the testis is IL1F8, although its function there is entirely unknown ([@b1435]).

### 11.10.4.2.3. Tumor necrosis factor α and Fas ligand {#s0095}

TNFα and FasL are transmembrane and secreted cytokines with typically trimeric structures and they interact with specific receptors to mediate a cell death signal ([@b1270], [@b2460]). They are implicated in both immunoregulation and the control of normal spermatogenic function in the testis.

TNFα is a 17 kDa glycosylated polypeptide and is a major early product of activated monocytes and macrophages. It binds to either of two TNF receptor subsets (TNFR1 and TNFR2) and plays a central role in initiating the inflammatory response by stimulating the production of IL1 and IL6 ([@b0190], [@b0305]). Whether TNFα exerts proinflammatory or cytotoxic effects depends on the receptor subtype engaged and the expression of specific adaptor proteins within the target cell ([@b0190], [@b0425], [@b1135], [@b1665]). Consistent with its name, TNFα exerts a cell death signal via TNFR1, through interaction with the TNFR-associated death domain protein (TRADD) or the Fas-associated death domain protein (FADD), and activation of the caspase-dependent apoptotic pathway ([@b2460]). However, interaction with TRADD can also result in recruitment of other adaptor proteins leading to the binding of TRAF2 and activation of the NFκB pathway and/or the MAP kinases Jnk or p38 ([@b0425]). Moreover, TNFR2 and its related receptors, which include CD40, do not contain a death domain, and instead associate with the TRAFs leading to activation of cell signaling events ([@b0305], [@b1665]).

In the mouse testis, TNFα is expressed by round spermatids, pachytene spermatocytes, and testicular macrophages, and mRNA for TNFR1 has been located on both Sertoli and Leydig cells ([@b0580]). In porcine Sertoli cells, TNFα receptor subunit protein expression is stimulated by FSH ([@b1710]). There is no evidence that TNFα is produced by the Sertoli cell, but expression of TNFα by the germ cells within the seminiferous epithelium, like that of IL1α and IL6, is cyclical. Within the seminiferous epithelium, TNFα produced by the germ cells appears to play a complex role in the control of both Sertoli cell function and spermatogenesis. TNFα reduces spontaneous germ cell degeneration in cultured human and rat seminiferous tubules, suggesting a germ cell survival effect presumably mediated through the Sertoli cell ([@b2125], [@b2675]). Conversely, TNFα disrupts Sertoli cell tight junction assembly by inhibiting the production of junction proteins and by regulating matrix metalloprotease and protease inhibitor activity ([@b2550]). TNFα also stimulates plasminogen activator inhibitor expression in rat testicular peritubular cells ([@b1475]). Similar to IL1, TNFα stimulates basal lactate production by cultured Sertoli cells, but TNFα generally antagonizes the actions of FSH on Sertoli cell function, including the stimulation of aromatase activity and lactate production ([@b1730], [@b1920], [@b2270]). However, [@b0620] have shown that TNFα stimulates androgen receptor expression in Sertoli cells via upregulation of NFκB, which binds to several enhancer motifs in the androgen receptor promoter. TNFα also stimulates the expression of inflammatory cytokines, chemokines, and leukocyte adhesion molecules in both Sertoli cells and peritubular cells ([@b0095], [@b0545], [@b2625]). In testicular pathology, TNFα has been implicated as a major causative agent in the development of experimental autoimmune orchitis (EAO) ([@b3115]). There is a significant increase in the number of TNFα-positive testicular macrophages and the number of TNFR1-positive germ cells undergoing apoptosis during EAO in rats ([@b2650]). Within the interstitium, TNFα acts as an effective regulator of Leydig cell steroidogenesis, by inhibiting LH receptor binding and steroidogenic gene expression ([@b1550], [@b1725], [@b1720], [@b3035], [@b3040]).

No intratesticular cytokine has excited more controversy than the cell death signaling ligand FasL. Interactions between FasL and its receptor on activated T cells are important in the regulation of the immune response ([@b1270]). The death domain in the cytoplasmic region of the Fas receptor recruits the FADD adaptor protein and induces T cell death via caspase-dependent apoptosis ([@b2460]). There is evidence that FasL expression on epithelial cells in immune-privileged tissues, including Sertoli cells, may be responsible for deleting activated T cells within the tissue, thereby suppressing adaptive immunity ([@b0205], [@b0920], [@b2370], [@b2640]). However, this hypothesis has been challenged by the observation that increased FasL expression on cells such as tumor cell lines and pancreatic islet cells does not increase protection in transplantation studies, but actually provokes a massive inflammatory reaction and rejection ([@b0055], [@b1295]). Moreover, FasL appears to be abundantly expressed in the epithelia of several human tissues that lack any evidence for immunological privilege ([@b3020]), while absence or inhibition of Fas or FasL does not automatically cause failure of immune privilege ([@b2330], [@b2645], [@b2870]). It seems unlikely that FasL expression on its own is a fundamental explanation for immune privilege, although it may contribute through interaction with other immunoregulatory processes ([@b0410]).

Localization of FasL and Fas in the testis under normal conditions also has proven controversial, which may be attributed to differences in detection methods, limitations of some of the reagents that have been used, and the fact that these molecules are inducible ([@b0520], [@b2255]). Studies have shown FasL to be present in rat, mouse, porcine, and human Sertoli cells and absent in most germ cells ([@b0205], [@b0310], [@b0515], [@b1485]), but other studies have reported that FasL expression in the rat seminiferous epithelium is confined to the germ cells ([@b0400], [@b0520]). The receptor Fas has been found on isolated mouse Sertoli cells ([@b2260]), but in intact testes has been localized to spermatogonia and spermatocytes from the pubertal period onward ([@b0400], [@b1485], [@b1590], [@b2015]). In germ cells, Fas expression is associated with cells that are undergoing apoptosis ([@b1485], [@b1590]), and Fas is induced by TNFα and IFNγ in the Sertoli cell ([@b2260]). Curiously, in one study using fragment cultures of human seminiferous tubules, TNFα downregulated FasL expression and inhibited apoptosis of germ cells ([@b2125]). Less controversially, Fas and FasL expression is upregulated in various models of seminiferous epithelium damage, indicating that this mechanism is important in regulating germ cell apoptosis in cases of physical and toxicological insult ([@b1485], [@b2015]).

### 11.10.4.2.4. Interleukin 6 and the gp130 family {#s0100}

Members of the IL6 family of cytokines exert their actions via binding to specific receptors that associate with a common membrane signal transducer gp130, leading to the activation of the Janus kinase/signal transducers and activators of transcription (Jak/Stat) and MAP kinase cascades ([@b1085]). In addition to their functions in inflammation and the immune response, these cytokines play crucial roles in hematopoiesis, liver and neuronal regeneration, embryonic development, and fertility. Members of this family that have been detected in the testis are leukemia inhibitory factor, oncostatin M, ciliary neurotropic factor, IL11, and IL6 itself ([@b0575], [@b0570], [@b0650], [@b1245], [@b2025], [@b2625]). The principal roles of most of these cytokines in the testis appear to lie in regulating Leydig cell development and the onset of spermatogenesis. A role in testicular immunology is most likely for IL6, which possesses both proinflammatory and anti-inflammatory properties, and regulates the acute-phase response as well as several aspects of immune cell development and activity ([@b1400], [@b2750]).

Sertoli cells, Leydig cells, and peritubular cells have been shown to produce IL6 *in vitro* ([@b0495], [@b2025], [@b2680], [@b2685]). In rat Sertoli cells, IL6 production is stimulated by FSH, testosterone, phagocytosis, and other inflammatory stimuli, including IL1α, IL1β, TNFα, and LPS ([@b0490], [@b0495], [@b2025], [@b2020], [@b2625], [@b2685]). Production of IL6 by cultured mouse Sertoli cells is inhibited by INFγ ([@b2260], [@b2625]). Within the seminiferous epithelium, endogenous production of IL6 follows a cyclical pattern that corresponds with the changes in the stages of the spermatogenic cycle, most probably under the influence of IL1α and FSH ([@b0965], [@b2680], [@b2685]). Both the IL6-specific receptor subunit (IL6R) and the gp130 mRNA are expressed in rat Sertoli cells, and are stimulated by IL1 and IL6, but only the IL6R subunit is stimulated by FSH ([@b0800]). IL6 increases basal and FSH-induced transferrin and cyclic GMP secretion by the Sertoli cell, and inhibits meiotic DNA synthesis in preleptotene spermatocytes ([@b0275], [@b0965], [@b1125]). In models of EAO, IL6 appears to play an ameliorative or protective role within the seminiferous epithelium ([@b1530], [@b2295]). Leydig cells are also active producers of IL6 following stimulation by LH, LPS, or IL1β *in vitro*, and evidence suggests that these cells actually may be the major testicular source ([@b0280], [@b0495], [@b2025], [@b2020]).

### 11.10.4.2.5. Interleukin 10 {#s0105}

Several studies have implicated IL10 as a key player in testicular immunology. Testicular IL10 production is preferentially induced by systemic LPS treatment in the adult rat testis ([@b1970]), and macrophages and T cells isolated from the rat testis constitutively produce IL10, which may contribute to testicular immune privilege (Hedger, unpublished data). In a mouse model of EAO, elevation of endogenous IL10 levels by adenoviral-mediated transfection of human IL10 was found to significantly reduce the incidence of immune activation, orchitis, and spermatogenic damage ([@b2920]). Although male mice deficient in IL10 do not show evidence of male fertility problems, intratesticular immune responses have yet to be examined in these animals ([@b1425]).

### 11.10.4.2.6. Nitric oxide and oxygen metabolites {#s0110}

Production of ROS, particularly by macrophages, is an important component of the early response to infection ([@b2710]). Significant ROS include the superoxide anion (${\text{O}_{2}}^{-}$), hydrogen peroxide (H~2~O~2~), the hydroxyl radical (HO·), nitric oxide (NO·), and the peroxynitrite anion (ONOO^−^). Most are products of normal cellular metabolism, but their production is stimulated during inflammation through the activity of the enzymes NADPH oxidase (nicotinamide adenine dinucleotide phosphate-oxidase) and iNOS ([@b0775], [@b1910]). These small molecules are cytotoxic to many microorganisms, although some play a more complex role in cell signaling processes. They also interact with crucial intracellular macromolecules, such as proteins, lipids, and DNA, causing oxidative damage. Although there are endogenous repair systems to correct oxidative damage, excessive production of ROS contributes to the pathology of many diseases.

Among the ROS, nitric oxide represents a special case. At high levels, NO is highly cytotoxic, especially as a precursor of the peroxynitrite anion, but at low levels NO acts as an intracellular and extracellular signaling molecule ([@b0270], [@b2435]). It is produced by one of three related enzymes, neuronal NOS (nNOS or NOS1), inducible NOS (iNOS or NOS2), and endothelial NOS (eNOS or NOS3), which catalyze the conversion of [l]{.smallcaps}-arginine to [l]{.smallcaps}-citrulline and NO ([@b0040]). The NOS enzymes are homodimeric proteins encoded by three separate genes ([Table 2](#t0010){ref-type="table"}). Both nNOS and eNOS are constitutively expressed enzymes whose activity is regulated through a calcium--calmodulin-mediated mechanism, whereas iNOS is a constitutively activated enzyme that is regulated at the transcriptional and translational levels by various inflammatory mediators, including LPS, IL1, and TNFα ([@b3000]). Table 2Major inflammatory enzymes -- properties and distribution in the testisEnzymePropertiesPrincipal cellular expression in normal testisNeuronal nitric oxide synthase (nNOS, type I)Ca/calmodulin regulated, constitutively expressedSertoli cell, Leydig cell, vascular endotheliumInducible nitric oxide synthase (iNOS, type II)Constitutively active, transcriptionally and translationally regulatedSertoli cell, Leydig cell, peritubular cell, pachytene spermatocytes and elongating spermatids, macrophage subsetEndothelial nitric oxide synthase (eNOS, type III)Ca/calmodulin regulated, constitutively expressedSertoli cell, Leydig cell, peritubular cell, vascular endotheliumPhospholipase A~2~Multiple classes and groups, various propertiesUbiquitous expressionCyclooxygenase 1 (COX1)Constitutively expressed, not induced by inflammationUbiquitous expressionCyclooxygenase 2 (COX2)Induced by inflammationSertoli cell, Leydig cell, peritubular cell, all spermatogenic cells

In studies in various species, NOS has been found in Sertoli cells, Leydig cells, peritubular cells, germ cells, testicular macrophages, and vascular endothelial cells ([@b1375], [@b1495]). The *nNOS* gene also produces a testis-specific isoform, TnNOS, which has been localized to Leydig cells ([@b2910]). In the normal rat seminiferous epithelium, iNOS is expressed by elongating spermatids and pachytene spermatocytes, particularly during the stages immediately following sperm release, with relatively lower levels of expression in Sertoli cells and peritubular cells throughout the entire cycle ([@b1980]). In the interstitium, macrophage expression of iNOS appears to be largely confined to the minority of CD163-negative macrophages of the testis, and is not detectable in the majority of resident macrophages even during inflammation ([@b1980], [@b0870]). Testicular cell iNOS expression and NO production are increased by inflammatory events induced by LPS, testicular torsion, or testicular heating ([@b1600], [@b1980], [@b2535]).

Production of NO by germ cells, in particular, is implicated in the control of the formation and disassembly of the Sertoli cell junctions that constitute the blood--testis barrier, as well as the junctional complexes involved in Sertoli--germ cell adhesion ([@b1490], [@b1500]). Moreover, pachytene and round spermatid apoptosis is significantly reduced in iNOS null mice, leading to an increase in daily sperm output and indicating a key role for iNOS in limiting germ cell survival and/or the carrying capacity of the Sertoli cells ([@b1600]). NO inhibits Leydig cell steroidogenesis directly, an action that is probably mediated through oxidative damage, and treatment with NOS inhibitors counteracts the normal decrease in testosterone associated with sepsis or stress ([@b0610]; Sharma *et al.* 1998; [@b2940]). Similarly, production of other ROS has been implicated in the loss of steroidogenic function in various inflammatory models and in Leydig cell cultures ([@b0855], [@b2200]). Last but not least, NO is a potent vasodilator, and plays a role in the endogenous control of testicular blood flow and formation of the interstitial fluid ([@b1580], [@b1980]). Production of NO is an important mediator of germ cell death in testicular torsion ([@b1855], [@b2535]), and may be involved in the testicular damage associated with varicocele ([@b2400], [@b2810]).

11.10.4.3. Inflammatory Signaling Pathways in the Seminiferous Epithelium {#s0115}
-------------------------------------------------------------------------

It is evident that the major inflammatory signaling pathways mediated via NFκB and the p38/Jnk MAP kinases play important, albeit complex, intratesticular roles. Notably, NFκB has been implicated as an apoptosis-inducing signal for germ cells in numerous studies ([@b1620], [@b2130], [@b2240], [@b2615]), even though it stimulates androgen receptor expression in the Sertoli cell ([@b0620]). Activation of p38/Jnk is implicated in the stimulation of proliferation by immature Sertoli cells and the regulation of blood--testis barrier dynamics, steroidogenesis, and multiple inflammatory responses, including the production of IL6, iNOS, monocyte chemoattractant protein 1, and leukocyte adhesion molecules, in the mature Sertoli cell ([@b0545], [@b0550], [@b1190], [@b1185], [@b2135], [@b2265]). While these pathways mediate many of the effects of inflammation on the testis, endogenous regulation of these pathways also appears to be involved in the normal functions of the seminiferous epithelium, as will be discussed later.

### 11.10.4.3.1. Interferons {#s0120}

The IFNs are functionally related cytokines with antiviral activity and they comprise three main groups (α, β, and γ), based on their structural relationships and major cellular sources ([@b1105], [@b1675]). The type I IFNs (IFNα and β) are produced by a variety of cell types in addition to leukocytes, and exert primarily antiviral and antiproliferative effects via the IFNα receptor (IFNAR). The type II IFNγ is produced by NK and NKT cells, activated T cells and, under certain conditions, by macrophages and dendritic cells ([@b2440], [@b2840]). It acts through a separate receptor, and regulates the activity of APCs as part of the adaptive immune response in addition to its antiviral functions. Hence, IFNγ is a type II IFN, but a type 1 cytokine.

Type I IFN production is stimulated through TLR3, which detects double-stranded viral RNA, and TLR4, the bacterial LPS receptor ([@b1105]). These two TLRs, which are expressed in the testis ([@b0245], [@b2265], [@b2610], [@b3005]), are able to induce the IFN transcription factor IRF3, via engagement of the TRIF adapter protein ([@b0035], [@b1105], [@b1990]). The regulation of IFNγ is cell specific and complex, but involves Jak/Stat signaling and various transcription factors, including NFκB and AP1 ([@b2440], [@b2840]). Its production is stimulated by type I IFNs and by IL18, among other cytokines. Viral infections stimulate type 1 IFN and, somewhat more surprisingly, IFNγ production by Sertoli cells, peritubular cells, Leydig cells, and testicular macrophages, leading to typical antiviral responses in the testis ([@b0595], [@b0600], [@b0605], [@b1140], [@b2610]). A role for IFNγ in maintaining testicular immune privilege has been indicated by the observation that mouse Sertoli cells upregulate their expression of the negative costimulatory ligand B7-H1 in response to IFNγ *in vitro*, but remain devoid of positive costimulatory molecules ([@b0525]). On the other hand, *in vivo* studies have identified IFNγ as a causative factor in EAO in mice ([@b1225]). Moreover, IFNγ stimulates Sertoli cell production of Fas and caspase 1, and is implicated as the mediator of Sertoli cell and germ cell apoptosis under various conditions ([@b1300], [@b2260]). These disparate observations are indicative of a complex relationship between IFNγ, the local immune system, and spermatogenesis.

IFN production also affects testicular steroidogenesis. Normal healthy men treated with human IFNα had significantly decreased serum testosterone levels in conjunction with normal serum gonadotropins, and both IFNα and IFNγ inhibit testosterone production in primary cultures of Leydig cells ([@b2065]). Studies using porcine Leydig cells indicate that IFNγ exerts its inhibitory effect on testosterone production at the level of cholesterol transport into the mitochondria, and inhibits expression of the steroidogenic acute regulatory (StAR) protein and the P-450 steroidogenic enzymes, cholesterol side-chain cleavage complex (P450scc) and 17α-hydroxylase/C17--C20 lyase (P450c17) ([@b2060], [@b2070]). These data indicate that IFNs may contribute to the decline in steroidogenic function of patients with viral infections, in particular. However, [@b0595], [@b0600] have shown that an increase in IFNα and IFNγ expression in Sertoli and Leydig cells of rats infected with Sendai virus was actually associated with an increase in testosterone production. These results suggest that indirect or secondary stimulatory effects on testicular steroidogenesis may be involved, providing further evidence that IFNs play a complex role in testicular function.

### 11.10.4.3.2. Transforming growth factor β and activin A {#s0125}

The three TGFβ family members that are expressed in mammals (TGFβ~1~, TGFβ~2~, and TGFβ~3~) are the archetypes of a much larger superfamily of mostly homo- and heterodimeric proteins, which includes the activins, the bone morphogenetic proteins (BMPs), inhibin, and anti-Müllerian hormone ([@b1570]). The TGFβs themselves are multifunctional growth and differentiation factors involved in many aspects of tissue remodeling and repair as well as regulation of the immune system ([@b0090], [@b0405], [@b1555]). Nearly all cells synthesize a form of TGFβ and possess functional receptors for these cytokines. Most TGFβ family ligands act via dual transmembrane serine/threonine kinase receptors, called type I and type II, which interact upon ligand binding ([@b0380], [@b0685], [@b1690]). Signals are transduced from the membrane to the nucleus through phosphorylation of the regulatory Smad signaling proteins, with Smads 2, 3, and 4 responsible for mediating TGFβ and activin signaling ([@b0530], [@b0535]).

All three mammalian TGFβ forms are differentially expressed by Sertoli cells, peritubular cells, and Leydig cells in the fetal and immature testis, but production declines considerably during sexual maturation ([@b0110], [@b0825], [@b1880], [@b2045]). In the postpubertal testis, they have also been localized to the germ cells ([@b0390], [@b2720]), and TGFβ receptors are found in both somatic and germ cells ([@b0390], [@b0890], [@b1470]). The TGFβs appear to be involved in testicular development by controlling, among other things, apoptosis of undifferentiated spermatogonia (gonocytes) ([@b2050]), seminiferous tubule formation, and Leydig cell differentiation ([@b0500], [@b0630], [@b1360], [@b1395]). In the adult testis, TGFβ~2~ and TGFβ~3~ regulate Sertoli cell tight junction dynamics, indicating a role in regulating the permeability of the blood--testis barrier to facilitate the passage of spermatocytes across the barrier during spermatogenesis ([@b1605], [@b3025]). However, the TGFβs are also potent inhibitors of the activity of immune cells, especially T cells, B cells, and NK cells ([@b0015], [@b0090], [@b0470], [@b1555], [@b2865]), suggesting a prominent role in creating testicular immune privilege. Accordingly, TGFβ~1~ contributes to the lymphocyte inhibitory activity of testis extracts ([@b2190]) and to the immunoprotective properties of Sertoli cells in cotransplantation studies ([@b2645]).

Activins are homodimers or heterodimers of homologous subunits, designated β~A~--β~E~, which are structurally related to the TGFβs ([@b0405], [@b0560]). Homodimers of β~A~ form activin A, which is widely expressed and has been extensively studied. Relatively less is known about the other activin forms, which appear to be both less abundant and less widely distributed. Activin A is a multifunctional growth factor and inflammatory regulator ([@b2145]), although activins were originally named for the ability of activin A and B, in particular, to stimulate pituitary FSH secretion ([@b0465], [@b1575]). Heterodimers of either β~A~ or β~B~ subunits with a homologous α subunit, are called inhibin A and inhibin B, respectively, and act as feedback inhibitors of FSH secretion from the pituitary ([@b2305]). Unlike the activins, inhibins are not widely produced, and their chief source is the Sertoli cell, the cellular target of FSH action ([@b0555], [@b1805]).

Activin functions are highly regulated. Like the TGFβs, they act via specific type I and type II transmembrane serine/threonine kinase receptors, linked to the Smad signaling pathway ([@b0725], [@b2825]). The inhibins are competitive inhibitors of activin receptor binding, but activin homodimers and heterodimers comprising the β~B~ and β~C~ subunits also appear to act as weak competitive agonists of activin A ([@b0330], [@b1670], [@b1785]). These interactions are modulated and/or facilitated by specific inhibitory coreceptor proteins, such as betaglycan and the BMP and activin membrane-bound inhibitor (BAMBI) ([@b1520], [@b1670], [@b2055]). Moreover, activin bioactivity can be effectively neutralized in the circulation by the high-affinity activin binding protein, follistatin ([@b1900]).

Activin A is abundantly produced in the testis, particularly during early testicular development ([@b0150], [@b0365]). Even in the adult rat, intratesticular fluid levels of activin A are 5--10 times higher than normal circulating concentrations ([@b1970]). The Sertoli cells appear to be the main source in the adult testis, although the βA subunit is expressed in most germ cells ([@b0365], [@b1285]), and activin A protein is present in the resident macrophages and mast cells ([@b2040], [@b2030]). Activin A is expressed at low levels throughout the cycle of the seminiferous epithelium, but there is a distinct peak of production immediately following spermiation, which is driven by the surge of ILα produced by the Sertoli cell at this time ([@b1285], [@b2030]). Activin receptors are expressed by most, if not all, of the somatic and germ cells in the testis ([@b0375], [@b0585], [@b0745], [@b1280]). Activin A exerts a complex regulation of germ cell, Sertoli cell, and Leydig cell proliferation and/or differentiation during development and in the adult ([@b0150], [@b0360], [@b1695], [@b1715], [@b1750], [@b1770]), and disorders of activin signaling are implicated in the onset of testicular cancer ([@b0625]).

Activin A is produced by activated monocytes, macrophages, dendritic cells, bone marrow stromal cells, and some lymphocytes ([@b0720], [@b2010], [@b2315], [@b3065]), and plays a facilitating role in early inflammation responses ([@b1255]). Consistent with its homology to the TGFβ proteins, however, activin A also possesses a repertoire of anti-inflammatory and immunoregulatory activities, and displays characteristics of a type 2 cytokine ([@b1045], [@b2010], [@b2900], [@b3100]). In various experimental systems, activin A has been found to antagonize the production and actions of IL1 and IL6, to inhibit critical T cell and B cell activation responses, and to induce macrophages to polarize toward the M2 phenotype ([@b0325], [@b0915], [@b2010], [@b2355]). Both Sertoli cells and testicular macrophages in culture respond to LPS by increasing activin A production ([@b2035]) (Hedger, unpublished data), and IL1 is a very potent stimulus for activin A production by the Sertoli cell ([@b2040], [@b2030]). The actual role of activin A in testicular inflammation remains unclear, since the high intratesticular levels of activin A are not affected by LPS treatment *in vivo* ([@b1970]), but a role for activin A in modulating testicular immune responses can be predicted.

### 11.10.4.3.3. Steroids {#s0130}

Androgens produced by the Leydig cells have immunosuppressive properties that contribute to differences in immunity between the sexes ([@b0505], [@b1810]). The majority of these effects are believed to be exerted at the level of the immune tissues, rather than by direct effects on circulating leukocytes, which lack classical androgen receptors ([@b0935], [@b2420]). Recently, however, it has been discovered that steroids can interact with membrane-bound G-protein-coupled receptors to trigger nongenomic responses ([@b0315], [@b2225]). Studies have shown that androgens alter \[Ca\] fluxes in lymphocytes and macrophages via such membrane-mediated interactions, affecting gene expression and function in the target cells ([@b0215], [@b2880], [@b3010]). Although studies of the role of androgens in suppressing immune responses, such as graft rejection, in the testis have been somewhat equivocal ([@b0370], [@b2485], [@b2970]), the observation that immune cells can respond directly to androgens has resurrected the intriguing possibility that androgens, and possibly other testicular steroids, may directly regulate immune cell activity within the testis and adjacent draining lymph nodes.

Glucocorticoids play an important role in modulating both testicular immunity and steroidogenesis via a complex extratesticular regulatory loop. During inflammation, proinflammatory cytokines activate the hypothalamic--pituitary--adrenal axis leading to increased secretion of glucocorticoids, which act through the ubiquitously expressed glucocorticoid receptors ([@b0345], [@b2410]). Glucocorticoids suppress innate and acquired immunity at multiple levels and are an essential control in the inflammatory/immune response. They inhibit the inflammatory response primarily by repression of NFκB, suppressing the production and actions of the proinflammatory cytokines, reducing adhesion molecule expression, and stimulating the production of anti-inflammatory cytokines ([@b0100], [@b0300], [@b1310]). Glucocorticoids also exert inhibitory effects at all levels of the hypothalamic--pituitary--Leydig cell axis ([@b0145], [@b0975], [@b0985], [@b1850]), thereby contributing to the inhibition of androgen production that accompanies local and systemic inflammatory events.

### 11.10.4.3.4. Bioactive lipids: Prostanoids and phospholipids {#s0135}

Prostaglandins (PGD, PGE, and PGF), prostacyclins (PGI), and thromboxanes (Tx), collectively called the prostanoids, are fundamental to many physiological processes, including inflammation and immunity. Prostanoids arise from hydrolysis of membrane glycerophospholipids to release the free fatty acid arachidonic acid through the action of one of the more than 20 enzymes with phospholipase A~2~ (PLA~2~) activity ([@b1420], [@b2425]). Arachidonic acid is in turn directed down the prostanoid synthetic pathway by the action of the cyclooxygenase (COX; also called prostaglandin-endoperoxide synthase) enzymes ([Figure 3](#f0015){ref-type="fig"}). There are two COX enzymes, which are the products of different genes: the constitutively expressed COX1 and an inflammation-induced form, COX2 ([Table 2](#t0010){ref-type="table"}) ([@b2565], [@b2715]). While conversion of arachidonic acid to the prostanoid precursor PGH~2~ by COX is the rate-limiting step, production of specific prostanoids depends on the activity of the prostaglandin synthases, that is, PGE synthase (PGES), PGIS, PGDS, PGFS, and thromboxane A synthase (TxAS) ([@b1095], [@b2815]). Each prostanoid acts via one or more specific receptors to regulate cell growth, vascular smooth muscle constriction or relaxation, vascular permeability, and immune cell activity ([@b0295], [@b1000]). Several prostanoids exert both proinflammatory and immunosuppressive actions through different receptor interactions, or through metabolism to other active immunoregulatory metabolites, such as 15-deoxy-PGJ~2~, a ligand for the peroxisome proliferator-activated receptor γ (PPARγ) ([@b1250]). An alternative synthetic pathway, catalyzed by the lipoxygenases, converts arachidonic acid to the related leukotrienes and lipoxins, which also possess diverse metabolic, vascular, and inflammation-regulating actions ([@b2385], [@b2700]). Figure 3Prostanoid and lysophosphatidylcholine synthesis and targets. Synthesis of the prostanoids commences through the action of phospholipase A~2~ (PLA~2~) on arachidonyl-containing phospholipids (usually a 1-acyl-2-arachidonyl-glycerophospholipid) to produce the free fatty acid arachidonic acid and the corresponding lysophospholipid. Arachidonic acid is converted into the prostanoid precursor prostaglandin H~2~ (PGH~2~) by the action of cyclooxygenases and this is further converted into the various prostanoid subtypes, prostaglandins (PGD, PGE, and PGF), prostacyclins (PGI), and thromboxanes (Tx), by the action of specific prostaglandin and thromboxane synthases. Synthesis of lipoxins and leukotrienes from arachidonic acid occurs via the activity of a separate lipoxygenase enzyme (not shown). The prostanoids interact with their various receptor subtypes: there are two PGD receptors (DP1--2) and four PGE receptors (EP1--4). It is the cellular expression of these receptor subtypes that ultimately determines the eventual biological responses; for example, different prostanoid and receptor combinations may produce either proinflammatory or anti-inflammatory responses, or may have opposing vasodilatory and vasoconstrictive effects. When the phospholipid is a phosphatidylcholine, a lysophosphatidylcholine (LPC) is formed, which may interact with cells via G-protein-coupled receptor-mediated or direct membrane interactions, or may undergo further enzymatic modification to form other bioactive lipids.

Most of the enzymes responsible for prostanoid production are ubiquitously expressed, and this includes the male reproductive tract ([@b0880], [@b1465], [@b2695], [@b2980]). In fact, the levels of E series prostaglandins in human seminal plasma are remarkably high ([@b0460]). Most testicular cells express both COX forms, and possess the capacity to produce prostaglandins *in vitro* ([@b2980]), although there appear to be cell type-specific and species-specific differences in the relative levels of expression ([@b0140], [@b0795], [@b1460]). In the normal rat testis, COX2 is responsible for the majority of prostaglandin production ([@b2980]), although intratesticular PGE~2~ levels are only marginally affected by acute inflammation ([@b2985]). This is probably due to the fact that macrophages in the rat testis express COX2 at very low levels, but are the only testis cell type to respond to an inflammatory stimulus with a significant increase in COX2 activity ([@b2980]). These data point toward a previously unanticipated maintenance role for the so-called inducible COX2 enzyme in testicular function, as well as an anomalous inflammatory response of testicular COX2, consistent with an altered capacity of this organ to initiate and support inflammatory reactions.

Fertility is retained in male mice lacking either COX1 or COX2, whereas double deletions are lethal ([@b1440], [@b1560], [@b2380]). Studies on male fertility and spermatogenesis using prostaglandins, or nonsteroidal anti-inflammatory drugs such as aspirin and indomethacin, which act primarily via inhibition of COX activity, have produced conflicting conclusions ([@b0005], [@b0260], [@b2405], [@b2985]). These diverse outcomes indicate the complexity of the roles of prostanoids in controlling various aspects of testicular function. Prostaglandins, particularly PGE~2~ and PGF~2α~, have been implicated in the control of Leydig cell development in the immature testis, production of proinflammatory cytokines by the Leydig and Sertoli cells, autoregulation of steroidogenesis in the adult, and the decline in Leydig cell function that occurs during aging ([@b0135], [@b0455], [@b0980], [@b1185], [@b2875], [@b2905]). Production of PGE~2~ and PGF~2α~ by COX2 also mediates the effects of IL1 on protein and lipid regulation by the Sertoli cell involved in supporting spermatogenesis and inflammation in the testis ([@b1190], [@b1185]). In addition, PGE~2~ and PGF~2α~ produced by mature spermatozoa play a role in the acrosome reaction ([@b0320], [@b1265]). Products of the lipoxygenase pathway, such as leukotriene B~4~, are also produced by the testis, where they intervene in the regulation of Leydig cell steroidogenesis by LH ([@b2090], [@b2655]), but other functions can be expected.

Direct evidence for the anticipated roles of prostanoids or lipoxygenase products in testicular inflammation and immunity is lacking. Initially, there was some evidence to suggest that PGE~2~ might be responsible for the immunosuppressive phenotype of resident testicular macrophages ([@b1340], [@b1345]). This now seems unlikely, because testicular macrophages produce little PGE~2~ under normal conditions, and blocking COX2 activity *in vivo* or *in vitro* does not affect the production of proinflammatory cytokines in the testis in response to LPS ([@b0870], [@b2980], [@b2985]). In the rat, chronic inhibition of COX2 inhibited interstitial fluid formation in normal testes, but ameliorated the loss of fluid that usually occurs during LPS-induced inflammation ([@b2985]). The latter data would seem to indicate roles for products of COX2 in the control of vascular tone in the normal and inflamed testis and this deserves further exploration.

When phosphocholine (PC)-containing phospholipids are used as the substrate for PLA~2~ action, lysophosphatidylcholines (LPCs) are also produced ([@b0075], [@b2570]). LPCs usually comprise a glycerophosphocholine backbone, a single long-chain fatty acid, and a free hydroxyl group ([@b1370]). The platelet-activating factors (PAFs) are a subset of LPCs with an acetyl group in place of the hydroxyl group, which facilitates binding to the PAF receptor ([@b2570]). The effective concentrations of these phospholipid-derived molecules in biological fluids are normally tightly controlled by binding to albumin and lipoproteins ([@b0485]), since some LPCs, particularly those derived from the saturated C16 and C18 fatty acids, cause cell lysis at high concentrations ([@b2945]). At physiological concentrations, however, LPCs induce specific responses in various cell types, including most immune cell types. Nonacetylated LPCs are chemotactic toward macrophages, T cells, and NK cells, and stimulate COX2 expression by macrophages, cytokine production by T cells, and the cytotoxic activity of NK cells ([@b1505], [@b2215], [@b2965], [@b3070]). In addition, LPCs induce apoptosis in T cells, indicating a role in immunosuppression as well ([@b1275], [@b2705]). The details of the mechanisms involved are poorly understood. While there is evidence for involvement of specific G-protein-coupled receptors ([@b0760], [@b1565], [@b2215], [@b2580], [@b3070]), LPCs may interact with G-proteins, membrane kinases, and ion channels directly, thereby bypassing the need for any specific receptor--ligand interactions.

The interstitial fluid of the testis has long been known to possess potent lymphocyte-inhibiting activity *in vitro* ([@b1070], [@b2185]). The molecules responsible for this activity have now been isolated and identified as the specific LPCs: 1-palmitoyl-*sn*-glycero-3-phosphocholine (16:0a-LPC), 1-oleoyl-*sn*-glycero-3-phosphocholine (18:1a-LPC), a 18:2a-LPC (putatively, 1-linoleoyl-*sn*-glycero-3-phosphocholine), and a 20:4a-LPC (putatively, 1-arachidonyl-*sn*-glycero-3-phosphocholine) ([@b0780]). These molecules inhibit T cell proliferation in response to activation and induce apoptosis of these cells in a time- and dose-dependent manner at physiologically relevant concentrations. Although PAF activity has also been found in the testis ([@b1875]), these acetylated LPCs did not appear to contribute significantly to the T cell inhibitory activity. The emergence of LPCs as regulators of critical immune events in the testis opens up new avenues of inquiry into the origins of autoimmune infertility and more general mechanisms of peripheral immunoregulation. These molecules may also have other roles in testis biology that demand consideration.

### 11.10.4.3.5. Cell surface regulatory molecules: Complement inhibitors and nonclassical MHC {#s0140}

Inhibition of complement activation is an important mechanism for reducing transplant rejection, particularly in the early phase. Membrane complement inhibitors, such as CD46, CD55, CD59, and the complement receptor-related protein (Crry), are expressed in several immune-privileged tissues and have been implicated in suppression of inflammation in the eye and placenta ([@b0285], [@b0350]). CD46 and CD55 appear to be confined to spermatids in the adult rat testis, Crry is expressed on early spermatocytes and interstitial cells, but CD59 is widely expressed throughout the seminiferous epithelium and interstitium ([@b1830]). A role for CD59 expression by the Sertoli cells in prolonging the survival of these cells in transplantation studies has been suggested ([@b1480]). Moreover, complement regulators both in seminal plasma and on the surface of the spermatozoa (CD46, CD55, and CD59) may contribute to complement evasion by the spermatozoa in the female tract ([@b0995]).

Classical MHC class I molecules (HLA-A, HLA-B, and HLA-C) are expressed on nearly all cell types, and facilitate antigen presentation by these cells and activation of cytotoxic T cells ([@b0480], [@b1235], [@b2395]). By contrast, the nonclassical MHC class Ib molecules (HLA-E, -F, and -G) are much less widely expressed, and are associated with suppression of the adaptive immune response. Membrane-bound and soluble variants of these MHC class Ib molecules have been implicated in the apoptosis of alloreactive cytotoxic T cells, inhibition of NK cell cytolytic activity, suppression of T cell proliferation, and deviation of type 1 to type 2 responses, most notably in pregnancy ([@b0120], [@b0785], [@b1195], [@b1305], [@b1290], [@b2280]). HLA-G has been found in the rhesus monkey testis ([@b2365], [@b2560]), and HLA-E is expressed on germ cells in the human testis ([@b0755]), indicating that these molecules may contribute to immune privilege in the testis.

11.10.4.4. Immune System--Testis Interactions in Normal Function and Pathology {#s0145}
------------------------------------------------------------------------------

From the evidence outlined in the previous sections, it should be evident that proinflammatory and immunoregulatory processes are involved in both normal testicular function and testicular pathophysiology. In the normal testis, roles in the maintenance of immune privilege, the control of Leydig cell development, and the fine regulation of spermatogenesis are indicated ([Figure 4](#f0020){ref-type="fig"}). Contributions to pathology include the development of autoimmunity within the male reproductive tract, disruption of steroidogenesis and spermatogenesis during systemic and local inflammatory events, and the response to vascular disturbances. Figure 4Inflammatory and immunoregulatory signaling in the control of intratesticular interactions. Sertoli cells are primarily regulated by the hormones follicle-stimulating hormone (FSH) and testosterone, the latter being produced by the Leydig cells on stimulation by luteinizing hormone (LH). Sertoli cells and germ cells interact through production of various inflammatory mediators, including interleukin (IL) 1α, IL6, activin A, tumor necrosis factor α (TNFα), and NO, to facilitate and coordinate critical events throughout the cycle of the seminiferous epithelium. The development and activity of the Leydig cells and the resident macrophages involve a close mutual interaction, mediated by mechanisms that remain to be completely defined. The Sertoli cell and the resident macrophages, in turn, influence the activity of the antigen-presenting cells (APC; e.g., dendritic cells) and lymphocytes within the interstitial tissue to control local immune events, such as the maintenance of an immunologically privileged environment. This communication involves the immunoregulatory cytokines transforming growth factor β (TGFβ), activin A, and IL10, although other mechanisms may also be involved.

### 11.10.4.4.1. Normal testicular function {#s0150}

Direct evidence that immune privilege is due to a specialized immune environment originally comes from studies involving the central nervous system. Injection of soluble antigen into the compartments of the eye or brain produces antigen-specific suppression of cell-mediated immunity, specifically type 1 reactions ([@b1315], [@b2950]). This phenomenon is called acquired immune deviation (AID), and it is possible to elicit similar inhibition of antigen-specific immune responses by prior injection of antigens into the testis ([@b0640], [@b1525], [@b2845]). The Sertoli cell and Leydig cell are almost certainly central to this process, although contributions from other testicular cells are to be expected. The mechanisms responsible presumably involve the recruitment and functional deviation of macrophages (and possibly dendritic cells) within the testis ([@b1035]), the subsequent recruitment of immunoregulatory lymphocyte subsets ([@b2770]), the production of immunoregulatory cytokines, such as TGFβ family members and IL10 ([@b1970], [@b2645]), local high concentrations of androgenic steroids, prostanoids, and other bioactive lipids ([@b0780], [@b2980]), complement inhibitors ([@b1480], [@b1830]), and testicular expression of inhibitory MHC and costimulatory molecules ([@b0525], [@b0755], [@b2365]).

Macrophages play an important role in Leydig cell development and function. There is a close temporal link between the maturation of the adult Leydig cell population and the increase in the number of testicular resident macrophages during puberty ([@b0990], [@b2210], [@b2850]). Reductions in intratesticular macrophages due to specific depletion methods or in the macrophage-deficient (*op/op*) mouse lead to disorders of Leydig cell development and mature function ([@b0440], [@b0835], [@b0840]), and testicular macrophage-conditioned medium stimulates Leydig cell steroidogenesis under certain conditions ([@b1930], [@b3080]). These supportive functions of the testicular macrophages may involve production of cytokines and other secreted mediators ([@b1365], [@b2915]), as well as the distinctive intercytoplasmic specializations that develop between the two cell types ([@b1170], [@b1825]). It has also been shown that testicular macrophages support basal steroidogenesis in the Leydig cells by providing 25-hydroxycholesterol as a substrate for testosterone biosynthesis ([@b1930]).

Endogenous regulation of inflammatory pathways within the seminiferous epithelium appears to be involved in the fine control of spermatogenesis. Studies in the rat and mouse indicate that nuclear localization (i.e., activation) of the key proinflammatory transcription factor NFκB, and expression of the inflammation-responsive genes, IL1α, TNFα, IL6, activin A, and iNOS, in the Sertoli cell and the germ cells describe cyclical patterns within the seminiferous epithelium that coincide with critical events in the cycle of the seminiferous epithelium ([@b1975]). Most notably, release of spermatozoa from the epithelium (spermiation) in the rat testis is followed by an increase in the production of IL1α, IL6, and activin A by the Sertoli cells and of TNFα and iNOS by the spermatocytes ([@b0580], [@b0965], [@b1285], [@b2575], [@b2680], [@b1980], [@b2030]). In the mouse, spermiation is accompanied by a period of elevated nuclear NFκB levels in spermatocytes ([@b0615]). These responses coincide with a peak of DNA synthesis by preleptotene spermatocytes and type A spermatogonia prior to meiotic and mitotic division, and reorganization of Sertoli cell tight junctions to allow the meiotic cells to enter the adluminal compartment ([@b1975]). Given that IL1α, IL6, and activin A are regulators of spermatogonial proliferation and meiotic progression ([@b0955], [@b0965], [@b1695], [@b1750], [@b1770], [@b2095], [@b2575]), while TNFα and iNOS/NO induce the disassembly of the intercellular tight junctions ([@b1490], [@b1500], [@b1535], [@b2550]), this concurrence of events is unlikely to be a coincidence. It would appear that release of the spermatozoa and/or phagocytosis of the residual cytoplasm triggers elements of the inflammatory machinery within the seminiferous epithelium. A role for TLRs or other pattern-recognition receptors in this process may be postulated, and similar regulatory networks may also operate throughout the remainder of the cycle. Many questions regarding the details of this functional regulation await clarification, and it must be noted that there is a curious lack of concordance between the content of NFκB in the Sertoli cell nucleus observed across the cycle in the mouse ([@b0615]) and inflammatory cytokine production by these same cells in the rat ([@b0580], [@b0965], [@b1285], [@b1980], [@b2030], [@b2575], [@b2680]). Regardless of the questions that remain, however, key elements of the inflammatory response appear to play essential roles in the physiological regulation of the seminiferous epithelium, which are entirely separate from their roles in pathology.

### 11.10.4.4.2. Testicular pathology {#s0155}

Although it is a common assumption that male reproductive failure caused by local or systemic illness, infection, and chronic inflammatory disease is due to the negative effects of raised body temperature on spermatogenesis, there is little clinical or experimental evidence to support this belief ([@b1985]). There is much more convincing evidence that the damage is due to activation of local inflammatory pathways and the activity of immune cells recruited during inflammatory events. As already outlined in the previous sections, inflammatory mediators such as IL1, ROS, TNFα, and NO, as well as glucocorticoids produced in response to inflammation, have mostly negative effects at all levels of the hypothalamic--pituitary--Leydig cell axis ([@b0145], [@b0610], [@b0970], [@b0975], [@b0985], [@b1550], [@b1725], [@b1720], [@b1850], [@b2525], [@b2940], [@b3035], [@b3040], [@b3045]). The subsequent reduction in androgen production may lead to reduced spermatogenic capacity, but may also exacerbate the effects of inflammation on spermatogenesis itself. Expression of TLRs on the Sertoli cells is obviously important in protective responses against pathogens, but also provides a mechanism whereby pathogens can directly inhibit spermatogenesis. Thus, TLR activation and the production of inflammatory mediators almost certainly alter Sertoli cell functions, and this will affect the ability of these cells to support and regulate spermatogenesis, as well as activate signaling pathways that promote germ cell apoptosis ([@b1620], [@b2130], [@b2240], [@b2615]).

Inflammatory events play a role in testicular damage due to vascular disturbance. Spermatogenesis is an energy intensive process, and the seminiferous epithelium is not vascularized. Consequently, unobstructed blood flow to the testis is essential and even minor anomalies in the testicular vasculature, such as varicocele, have cumulative negative effects on sperm production ([@b1240]). The deleterious effects of cadmium on fertility through disruption of the testicular vasculature are well known ([@b2445]). In experimental animals, transient torsion of the spermatic cord that renders the testis ischemic followed by reperfusion causes an increase in TNFα and IL1β expression, activation of the stress-related Jnk/p38 MAP kinase signaling pathway, neutrophil recruitment and infiltration into the testis, increased oxidative stress, germ cell apoptosis, and significantly decreased serum testosterone levels ([@b1615], [@b1625], [@b2325]). A specific role for testicular nitric oxide in mediating damage in both the testicular torsion and human varicocele models has been implicated ([@b1855], [@b2400], [@b2530], [@b2535], [@b2810]).

Administration of high doses of human chorionic gonadotropin (hCG), a treatment used to correct delayed testicular descent in young boys, causes a hyperstimulation syndrome in rats comprising increased testicular blood flow and pressure, increased vascular permeability, and accumulation of interstitial fluid ([@b1115], [@b2515], [@b2835]). These vascular changes are accompanied by accumulation of intravascular and interstitial neutrophils in the testis ([@b0240], [@b2975]), and spermatogenic damage ([@b1350], [@b1355]). The responses to hCG can be eliminated by depletion of either the Leydig cells or the neutrophils ([@b2510], [@b2975]), and IL1β is able to replicate most of the effects ([@b0235], [@b0225]), suggesting that the response involves an inflammatory event mediated via IL1β secreted by the Leydig cells. Thus, it appears that disruption of the seminiferous epithelium in both the ischemia/reperfusion model and hCG hyperstimulation models is directly linked to local recruitment of neutrophils. Exactly how these cells exert damage on the germ cells is not yet known, but increased oxidative stress is obviously involved. The responses are quite different from those observed in LPS-induced inflammation, which paradoxically causes a large reduction in interstitial fluid volume and an increase in mononuclear cells in the rat testis ([@b1985], [@b0870], [@b0875]), although the germ cell damage is similar in both models.

In summary, different testicular inflammation models have direct effects on spermatogenic development, in addition to causing damage to the steroiodogenic function of the Leydig cells. It should also be noted that, as in most other tissues, inflammation responses within the testis do not automatically lead to autoimmune complications, but damage to various testicular functions that may be less readily apparent may lead to longer-term consequences for reproductive health ([@b2450], [@b2455], [@b2665]).

11.10.4.5. The Epididymis, Vas Deferens, Accessory Glands, and Urogenital Tract {#s0160}
-------------------------------------------------------------------------------

As already noted above, the immune environment of the remainder of the male tract is quite distinct from that of the testis, or even from that of other mucosal tissues. The mechanisms whereby sperm within the male reproductive tract are protected from the immune system remain largely unknown, but an intact tract is obviously important. In humans, vasectomy leads to sperm antibody formation in approximately 70% of cases, and sperm antibodies are also associated with obstructive azoospermia and congenital absence of the epididymis and/or vas ([@b0045], [@b0565], [@b1090], [@b2100]). The incidence of antibody formation in humans appears to be directly related to the distance of the lesion from the testis, implying a limited role for elements of testicular immune privilege in preventing immune reactions. There is evidence from patients and animal models that vasectomy can have deleterious effects on the testis and epididymis as well, and that at least some of these effects may have an immunological basis ([@b0020], [@b0255], [@b0765], [@b2235]). In certain strains of rats, mice, and rabbits, vasectomy rapidly leads to orchitis and sterility, so it is not clear why this degree of damage is so rare in humans. In reality, the immunology of the male reproductive tract has yet to be investigated in depth, but two areas of recent interest are worth highlighting: the TLRs and the defensins.

Given the exposure to the external environment, it is not surprising that the TLRs as well as many essential TLR-related genes, such as MyD88, are expressed throughout the male reproductive tract, including the epididymis, vas deferens, and accessory glands ([@b1940], [@b2085], [@b2205], [@b2320]). Expression is found on both epithelial cells and leukocytes in these tissues. Moreover, weak expression of TLR11, originally localized to the urinary tract of experimental rodents, has been detected in the epididymis and vas deferens of the rat ([@b1455], [@b2085], [@b3130]). The importance of these molecules in acute and chronic inflammation, and the response to infection, in the male reproductive tract is an important area for future studies. Moreover, changes in susceptibility to inflammation through polymorphisms in the TLRs have been associated with differences in susceptibility to the onset of cancer in the prostate ([@b2660], [@b3135]).

Defensins are small (3--4 kDa) positively charged peptides that are able to disrupt bacteria, fungi, parasites, and some enveloped viruses by forming multimeric pores in the pathogen membrane ([@b2490]). The β-defensins are produced by most mucosal epithelial tissues, including the testis and epididymis ([@b0445]), and their production is stimulated via TLR activation and cytokines. A number of epididymal-specific β-defensins have been identified in the mouse and the rat ([@b1540], [@b1230], [@b3055], [@b3085], [@b3140]), and a role for androgen in their regulation has been indicated ([@b1230], [@b3085]). Apart from their obvious role in protection against pathogens, defensins may have other functions in the reproductive tract. The novel β-defensin, Bin1b, which is exclusively produced and secreted by the rat caput epididymis, binds to sperm ([@b1540], [@b3140]), and blocking Bin1b reduces sperm motility *in vivo*, suggesting a novel role for this molecule in sperm maturation ([@b3140]).

11.10.4.6. Sperm, Semen, Seminal Leukocytes, and Cytokines {#s0165}
----------------------------------------------------------

In humans, semen is the most accessible window into the health of the male reproductive system, as it is the number and quality of sperm in the semen that provide the principal foci for male reproductive toxicity outcomes. However, semen is a complex secretion, comprising many components, including leukocytes, immunoglobulins, cytokines, prostaglandins, and various immunosuppressives. Changes in the number or activity of these immunological components of the semen are also potential indicators of toxic actions within the tract.

Elevated numbers of leukocytes in the semen are generally considered to be an indication of infection, but leukocytes are present even in the semen of men with normal fertility ([@b0025], [@b0175]). The origin of these cells is somewhat obscure. Evidence suggests that the epididymis or vas may be a major source ([@b0060], [@b2465]), but the main leukocyte subset present in most semen samples are neutrophils, which are not a normal feature of the tissues of the genital tract ([@b0025], [@b0710], [@b2990]). The impact of these cells on fertility is also poorly understood. Some studies have shown a relationship between leukocytospermia and impaired sperm function ([@b0105], [@b0115], [@b0220], [@b2995]), and some data suggest that these cells might be a cause of sperm damage due to production of ROS and cytokines ([@b1110], [@b2760]). Moreover, leukocytes may attack the sperm directly, particularly in the presence of sperm autoantibodies, and may provoke or mediate hostile responses in the female tract. Other studies, however, have failed to confirm a clear link between seminal leukocytes and infertility or sperm antibody formation ([@b0030], [@b0170], [@b2755]), and it has even been suggested that leukocytes might play a beneficial role by removing abnormal sperm or by assisting in sperm capacitation ([@b2765], [@b2755]).

Molecules with immunomodulatory properties in seminal plasma include immunoglobulins, cytokines, and immunosuppressives. Both IgG and IgA are the major constituents of seminal plasma, and there appears to be a negative correlation between IgA concentrations and lymphosuppressive activity in seminal plasma ([@b0695], [@b1175], [@b1840]). These antibodies may play either protective roles in the control of immunity and infection, or destructive roles, when directed against functional elements of the sperm. Proinflammatory cytokines such as IL1α, IL2, IL6, IL8, IL12, IL17, TNFα, and IFNγ are found in all seminal plasma samples, even those from men with apparently normal fertility ([@b0690], [@b1150], [@b1405], [@b1645], [@b1915], [@b2165]). This is not particularly surprising, as these cytokines are present in most biological fluids and are modulated by the general health status of the individual. Soluble IL2 and IL6 receptors, molecules that modulate the activity of their respective cytokines, have also been found in seminal plasma ([@b1150]). Numerous studies have shown that proinflammatory cytokines are dramatically elevated in patients with inflammation and/or leukocytospermia ([@b0690], [@b1410], [@b1645], [@b1815], [@b2230]). However, specific positive and negative associations with other forms of infertility have also been reported ([@b0690], [@b0945], [@b1150], [@b1595], [@b1915]).

Seminal plasma has profoundly immunosuppressive properties, as defined by the ability to inhibit various T cell and NK cell activities *in vitro*. This inhibitory activity has been attributed to a number of seminal factors, including prostasomes ([@b1330]), oxidized polyamines ([@b0050]), prostaglandins of the E series ([@b2555]), nonspecific lymphocyte-suppressing proteins ([@b1630], [@b2855]), and immunoregulatory cytokines ([@b0065], [@b1150], [@b1595], [@b1815], [@b1955], [@b2230], [@b2605]). The main cytokines with immunosuppressive activity in human seminal plasma are TGFβ1, TGFβ2, IL10, and activin A. Immunosuppressives are believed to play a role in preventing lymphocyte responses against sperm autoantigens in the male and female reproductive tracts ([@b2310], [@b2005]).

11.10.5. General and Toxicological Issues {#s0170}
=========================================

In the current state of understanding of the interactions between the male reproductive tract and the immune system, many questions still remain. Nonetheless, it is clear that the mammalian testis in particular displays a special, if not unique, relationship with the immune system, involving distinctive cell--cell interactions and shared cytokines. Recently, microarray analysis of testicular gene expression signatures in human spermatogenic failure were found to correspond with gene sets usually associated with inflammation and autoimmune disease ([@b2590]). This relationship between reproduction and immunology impacts upon normal function, since perturbations in one system caused by toxicants will almost certainly impinge upon the other system. This extends into the characteristic responses of the testis to toxins and various pathologies ([Figure 5](#f0025){ref-type="fig"}). The complexity and potential consequences of these interactions may be appreciated by consideration of the following propositions:1.*If leukocytes play a role in maintaining normal testicular function, then drugs and toxicants that reduce macrophage and lymphocyte function or numbers may also have an indirect effect on testicular function.* The effect of dichloromethylene diphosphonate on macrophages in the rat provides a good experimental example of this possibility, by demonstrating that the loss of functioning macrophages leads to a decline in androgen levels and retarded Leydig cell development ([@b0230], [@b0835]). Inhibition of macrophage and lymphocyte functions or numbers may also compromise the immune-privileged status of the testis, potentially leading to testicular autoimmune disease. A related subset would involve chemicals that have direct action on both the immune system and testicular function, such as cyclosporin and cyclophosphamide ([@b0395], [@b1775], [@b2470], [@b2960]), which are commonly used to suppress graft rejection response and in the treatment of some autoimmune diseases.2.*Drugs or toxicants that induce inflammation may interfere with normal testicular function.* The serious consequences for testicular function associated with immune activation and inflammation are illustrated by the experimental model of LPS administration, which leads to Leydig cell dysfunction and testicular failure ([@b0420], [@b2885], [@b1985]). Any drug or toxicant that induces macrophage activation (e.g., bacterial toxins, carbon monoxide, sulfur dioxide) has the potential to induce testicular production of inflammatory cytokines, such as IL1β, TNFα, and IFNγ, as well as ROS, which may interfere with Leydig cell function and spermatogenic development, or local immunoregulation. The danger hypothesis model of autoimmune disease may be particularly relevant in this instance ([@b1705]). At least one of the putative 'danger' molecules (i.e., TNFα) is endogenously produced in the testis, potentially presenting a continuous challenge to the testicular immune system.3.*Drugs or toxicants that induce autoimmune disease or allergy may also induce testicular autoimmune disease.* There are many drugs that induce polysystemic autoimmune disease and this may also include reactions against the germ cells. An example here is polyarteritis nodosa, a necrotizing vasculitis of small arteries, which frequently involves the testis ([@b0735]). Sulfonamides, penicillin, phenytoin, arsenicals, thiouracil, iodides, and thiazides are frequently suspected as causes of this condition ([@b1965]). Likewise, mutagens and other toxins that may alter T and B cell receptor repertoires to create self-reactive lymphocytes could also contribute to the onset of autoimmune disease in the male reproductive tract.4.*Drugs or toxicants that affect testicular cell development or viability may also induce immune responses.* There are drugs or toxicants that affect Sertoli--Sertoli and Sertoli--germ cell junction stability, as well as agents that damage the Sertoli cell or germ cells directly, resulting in massive germ cell death, which may overwhelm the normal immunoregulatory capacity of the testis. Examples of this interaction are seen after testicular heating, serotonin administration, or treatment with ethane dimethane sulfonate (EDS) or other testicular toxicants, which are frequently followed by transient immune and/or inflammatory events ([@b0475], [@b1060], [@b2080], [@b2895]). Even if the epithelium recovers fully, there is the potential for sperm antibody development, leading to reduced fertility. Increased exposure to estrogenic compounds is associated with activation of immune cells in the testis, most notably the macrophages, providing evidence for a mechanism whereby environmental estrogens may affect male fertility indirectly via effects on local immunity ([@b1545]).5.*Testicular toxicants that alter steroidogenic cell function will have a direct effect on the immune system.* Toxicants that damage Leydig cells and reduce steroid production possibly could alter thymus function, leading to an enhanced susceptibility to autoimmune disease. Balanced against this is the likelihood that other androgen-deficiency symptoms are far more likely to be manifest and treated. All these interactions, however, illustrate to one degree or another the difficulty of separating direct effects of toxic agents on the immune cells and on the testis. Figure 5Model of toxicant actions and potential immunological consequences in the testis. Toxicants may damage or alter the function of somatic cells (in particular the Sertoli and Leydig cells), immune cells, or germ cells, thereby inhibiting androgen production and spermatogenesis, leading to increased germ cell death. This damage may lead to an overt inflammatory event (orchitis) through activation of the proinflammatory activities of local macrophages, which may exacerbate or prolong the testicular dysfunction. These events may be followed by a full or partial recovery of normal function, but intratesticular immune cell numbers and activity may become permanently altered, with possible implications for future toxic or inflammatory episodes. In certain circumstances, which may depend upon the severity of the initial damage caused or the genetic background of the patient, the antigen-presenting activity of intratesticular dendritic cells or macrophages may also be activated. This may lead to recruitment and activation of testicular antigen-specific T cells, development of cytotoxic T cells (CTL), and B cell antibody (Ig) production. This subsequent autoimmunity may have a more permanent effect on testis or sperm function (epithelial destruction or sperm antibody formation).

11.10.6. Conclusions {#s0175}
====================

There is a dynamic relationship between the male reproductive tract and the immune system that should be considered when assessing the effects of various toxicants on male fertility and reproductive development. The effects of toxicants on male reproductive functions, most notably the production of androgenic steroids, will in turn impinge upon the functions of the immune system. Many mechanisms underlying these interactions have begun to emerge in recent years, but a complete picture remains hidden. Further studies will no doubt lead to important new concepts concerning this relationship and its implications for reproductive toxicology.
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